Venous thromboembolism

I9_VTE

Phlebitis: Inflammation of a vein.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I26, I80, O87.1, O88.2 Hospital discharge: ICD-9 — 415\|451\|6713\|6714\|6732 Hospital discharge: ICD-8 — 450\|451\|671\|6739 Hospital discharge: excluded ICD-10 — I80.0# Hospital discharge: excluded ICD-9 — 4510 Cause of death: ICD-10 — I26, I80, O87.1, O88.2 Cause of death: ICD-9 — 415\|451\|6713\|6714\|6732 Cause of death: ICD-8 — 450\|451\|671\|6739 Cause of death: excluded ICD-10 — I80.0# Cause of death: excluded ICD-9 — 4510 2 out of 7 registries used, show all original rules.	28752
4. Check minimum number of events None	28752
5. Include endpoints None	28752
6. Filter based on genotype QC (FinnGen only)	27928

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2

NAME	I9_VTE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I26\|I80\|O871\|O882
HD_ICD_9	415\|451\|6713\|6714\|6732
HD_ICD_8	450\|451\|671\|6739
HD_ICD_10_EXCL	I800
HD_ICD_9_EXCL	4510
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I26\|I80\|O871\|O882
COD_ICD_9	415\|451\|6713\|6714\|6732
COD_ICD_8	450\|451\|671\|6739
COD_ICD_10_EXCL	I800
COD_ICD_9_EXCL	4510
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Venous thromboembolism based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	248674	138776	106624
Only index persons	178972	102819	76153
Unadjusted period prevalence (%)
Whole population	3.54	3.97	2.98
Only index persons	3.41	3.78	2.91
Median age at first event (years)
Whole population	65.14	66.44	63.36
Only index persons	62.36	63.33	61.06

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	27928	15076	12852
Unadjusted period prevalence (%)	5.60	5.35	5.89
Median age at first event (years)	60.98	58.95	63.37

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
28745: Matched controls
277576

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R50.9

ICD-10 Finland

Fever, unspecified

1.9

317.0

4426

23784

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

316.9

4973

27769

J01MA12

ATC

levofloxacin; systemic

1.8

312.9

5712

33419

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

79.4

307.7

6491

1016

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

307.7

5518

29084

130

Kela drug reimbursment

Malignant tumour

2.3

307.7

2982

13530

H02AB02

ATC

dexamethasone; systemic

2.3

307.7

3821

17026

D68.8

ICD-10 Finland

Other specified coagulation defects

16.3

307.7

861

524

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

179.5

307.7

2341

137

GD1UN

NOMESCO Finland

Lung circulation SPECT

12.0

307.7

377

308

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

29.9

307.7

918

306

I87.0

ICD-10 Finland

Postthrombotic syndrome

42.2

307.7

311

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

70.7

307.7

2011

295

45100

ICD-8 Finland

Phlebitis and thrombophlebitis, Of lower extremities

+∞

307.7

1139

R06.0

ICD-10 Finland

Dyspnoea

2.4

307.7

9828

49570

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

97.1

307.7

5659

699

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

104.7

307.7

2398

241

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

12403

79994

K93

ICPC

Pulmonary embolism

88.2

307.7

1367

157

I80

ICD-10 Finland

Phlebitis and thrombophlebitis

9.6

307.7

787

812

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

7.3

307.7

5587

8911

R60.0

ICD-10 Finland

Localized oedema

2.4

307.7

4558

19999

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.9

307.7

868

1452

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

6.3

307.7

1218

1939

A02BC02

ATC

pantoprazole; systemic

1.7

307.7

19373

153542

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.4

307.7

3810

16795

B01AB10

ATC

tinzaparin; parenteral

3.6

307.7

4592

13951

K94

ICPC

Phlebitis/thrombophlebitis

15.6

307.7

1350

872

Z51.5

ICD-10 Finland

Palliative care

2.3

307.7

2754

12220

JN4BD

NOMESCO Finland

Extensive body CT

2.2

307.7

3565

16440

JN4AD

NOMESCO Finland

Body CT examination

2.2

307.7

3371

15852

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1143.1

307.7

11923

172

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

307.7

4877

20647

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

127.5

307.7

4343

387

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

307.7

3368

15985

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

307.7

6703

39306

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

+∞

307.7

1366

GD2SN

NOMESCO Finland

Lung ventilation SPECT

11.3

307.7

443

385

B01AA03

ATC

warfarin; systemic

5.8

307.7

12800

33899

N02AA05

ATC

oxycodone; systemic

2.2

307.7

6452

31677

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

13.5

307.7

1552

1170

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

7.1

307.7

8420

15313

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

7.0

307.7

2461

3684

B01AF02

ATC

apixaban; oral

3.4

307.7

6256

20799

I26

ICD-10 Finland

Pulmonary embolism

80.0

307.7

1260

159

B01AB04

ATC

dalteparin; parenteral

4.5

307.7

2779

6404

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

307.7

5837

32643

N02AX02

ATC

tramadol; systemic, rectal

1.7

307.7

12936

89260

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

14.0

307.7

1553

1130

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

307.7

3984

18440

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

945.2

307.7

3672

A46

ICD-10 Finland

Erysipelas

2.1

307.7

4938

25174

H02AB06

ATC

prednisolone; systemic

1.6

307.7

13791

99636

4151A

ICD-9 Finland

Acute pulmonary heart disease, Pulmonary embolism and infarction

+∞

307.7

464

B01AB05

ATC

enoxaparin; parenteral

4.3

307.7

15288

58066

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.1

307.7

1629

5261

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

307.7

6867

38537

C03CA01

ATC

furosemide; systemic

2.0

307.7

11073

65375

B01AF01

ATC

rivaroxaban; oral

3.1

307.7

5703

20345

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

449.7

307.7

682

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

307.7

14938

96343

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

307.7

8735

49927

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

292.7

3495

17748

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

291.8

5656

33598

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.4

283.5

1075

3149

A04AA01

ATC

ondansetron; systemic, rectal

2.2

276.8

2462

11152

R4110

NOMESCO Finland

Physiotherapy

1.6

271.9

7778

51181

N03AX16

ATC

[U] pregabalin

1.7

257.9

6619

42272

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.8

250.2

1328

4722

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

250.0

8344

56773

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

248.1

11051

80208

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

247.2

3025

15440

I80.2

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

+∞

247.0

240

AA1AD

NOMESCO Finland

CT of head and brain

1.6

246.6

7952

53632

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

246.3

9661

68154

N02BE01

ATC

paracetamol; systemic, rectal

1.8

245.2

24843

216316

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

243.9

4334

24954

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

241.1

1927

8328

A04AA02

ATC

granisetron; systemic, transdermal

2.3

240.1

1930

8361

ZX120

NOMESCO Finland

Intravenous

2.0

239.7

2815

14151

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.5

231.2

1553

6205

ZXD05

NOMESCO Finland

Urgent procedure

1.6

230.8

8241

56733

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

222.6

6529

42863

J01DB01

ATC

cefalexin; oral

1.6

220.5

22456

191806

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

220.1

8824

62183

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

219.9

3313

18087

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

219.2

1756

7589

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

218.0

11887

89247

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

216.4

3971

23011

Z3226

NOMESCO Finland

Physiotherapist

1.7

216.1

5014

31002

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

213.5

5130

31999

J01FF01

ATC

clindamycin; systemic

1.6

212.0

7270

49406

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

209.8

9441

68013

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

203.9

4507

27464

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

203.2

6912

46812

L28

ICPC

Limited function/disability (L)

1.6

202.7

5165

32653

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

202.1

7799

54294

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.2

200.9

827

2544

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

199.9

9664

70469

45001

ICD-8 Finland

Pulmonary embolism and infarction, Embolia

+∞

197.6

192

A28

ICPC

Limited function/disability NOS

1.6

197.2

5059

32010

R02

ICPC

Shortness of breath/dyspnoea

1.8

196.6

3670

21323

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

196.1

4533

27923

L14

ICPC

Leg/thigh symptom/complaint

2.0

195.0

2292

11488

J01MA02

ATC

ciprofloxacin; systemic

1.5

192.7

10817

81069

D68.2

ICD-10 Finland

Hereditary deficiency of other clotting factors

16.3

191.6

165

R03AC02

ATC

salbutamol; inhalant

1.4

189.5

14125

111508

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

189.0

1462

6214

WX892

NOMESCO Finland

Monitored bed care

2.0

188.9

2223

11142

K99

ICPC

Cardiovascular disease other

2.9

188.8

950

3277

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.6

187.5

1133

4295

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

186.1

4622

28963

Z3231

NOMESCO Finland

Registered nurse

1.5

184.2

7362

51443

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

184.0

4338

26818

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.6

182.4

1123

4296

L17

ICPC

Foot/toe symptom/complaint

1.5

182.2

7509

52780

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

181.8

3859

23197

I82

ICD-10 Finland

Other venous embolism and thrombosis

12.5

180.9

181

141

A08

ICPC

Swelling

2.2

177.6

1563

7011

SPAT1254

SPAT

Administration of medicine

1.7

175.3

4107

25317

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

172.4

4865

31388

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

170.6

4939

32050

A06AD11

ATC

lactulose; oral

1.6

170.3

4369

27538

J01MA14

ATC

moxifloxacin; systemic

1.9

170.1

2493

13430

O22.3

ICD-10 Finland

Deep phlebothrombosis in pregnancy

28.8

169.5

116

L01BC06

ATC

capecitabine; oral

2.4

169.4

1183

4801

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

168.9

2494

13466

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

168.6

1670

7845

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

168.5

9107

67300

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

167.3

2099

10741

R53

ICD-10 Finland

Malaise and fatigue

1.5

165.7

6324

43597

S97

ICPC

Chronic ulcer skin

2.0

165.0

1816

8872

M04AA01

ATC

allopurinol; systemic

1.7

161.9

3822

23565

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

161.6

2945

16930

B01AX05

ATC

fondaparinux; parenteral

4.9

161.0

357

704

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.0

160.7

721

2332

D68.9

ICD-10 Finland

Coagulation defect, unspecified

9.7

160.2

190

191

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

160.1

2602

14462

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.0

159.1

735

2417

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

157.7

2877

16539

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

156.8

2245

11991

PH2AE, ,

SPAT

3.6

153.2

527

1447

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

6.7

151.4

244

355

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.7

150.4

814

2916

R03BB04

ATC

tiotropium bromide; inhalant

1.7

150.4

2932

17159

Z2446

NOMESCO Finland

Social worker

2.0

150.0

1650

8052

ZXE00

NOMESCO Finland

One hour or less

1.4

149.4

9942

75843

I82.80

ICD-10 Finland

Emboli and thrombosis in the subclavian vein

15.0

147.8

133

UJF32

NOMESCO Finland

Coloscopy

1.5

146.8

7062

50776

SPAT1229

SPAT

Assessment of need for aid

1.8

145.3

2268

12436

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.7

145.2

821

3008

Z86.7

ICD-10 Finland

Personal history of diseases of the circulatory system

30.3

144.0

WW500

NOMESCO Finland

Blood transfusion

2.3

143.6

1160

5014

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.7

142.9

2663

15378

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

142.2

4331

28309

L03AA13

ATC

pegfilgrastim; parenteral

2.2

140.8

1185

5210

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

4.0

139.8

403

978

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

137.2

3708

23556

H02AB07

ATC

prednisone; oral

1.6

137.1

3693

23442

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

136.5

3564

22454

WZC30

NOMESCO Finland

Teaching

1.6

136.3

4020

26061

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

135.6

2589

15040

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

134.7

1176

5247

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2.7

134.5

739

2667

J01DA01

ATC

[U] cefalexin

1.4

134.1

16123

134440

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

133.6

1433

6922

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

133.5

7656

56655

PHD99

NOMESCO Finland

Resection of other vein

2.0

132.7

1646

8370

L04AA06

ATC

mycophenolic acid; systemic

3.1

132.4

563

1764

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

131.8

2810

16814

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.6

131.6

443

1199

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

129.5

1457

7160

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

128.8

1402

6807

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

127.6

12721

102750

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

127.4

1063

4655

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

127.1

843

3336

4538X

ICD-9 Finland

Other venous embolism and thrombosis, Of other specified veins

9.8

126.7

149

148

N05CF01

ATC

zopiclone; oral

1.4

126.5

8687

66148

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

125.8

3189

19920

SPAT1255

SPAT

Intravenous administration of medicine

1.9

125.7

1844

9903

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

2.3

125.6

966

4086

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

125.2

1255

5910

C03DA01

ATC

spironolactone; oral

1.6

124.4

3341

21158

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

123.9

5725

40642

N03AX12

ATC

[U] gabapentin; oral

1.5

121.2

4127

27552

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

8.8

121.0

154

170

R52.9

ICD-10 Finland

Pain, unspecified

1.7

119.8

2454

14509

H02AB04

ATC

methylprednisolone; systemic

1.5

118.9

3715

24333

L03AA02

ATC

filgrastim; parenteral

2.4

118.8

824

3328

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

118.6

1626

8541

A04AA55

ATC

palonosetron, combinations; systemic

2.3

118.2

890

3729

R11

ICD-10 Finland

Nausea and vomiting

1.7

118.1

2151

12312

PH7YT

NOMESCO Finland

Dilatation of inferior vena cava or lower extremity vein with stent

64.8

118.0

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

117.6

1823

9951

WX002

NOMESCO Finland

Sedation and analgesia

1.5

117.6

4987

34782

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.1

117.4

1110

5109

Z2221

NOMESCO Finland

Medical doctor

1.4

117.3

6764

49890

S18

ICPC

Laceration/cut

1.3

116.3

11692

94095

E66.8

ICD-10 Finland

Other obesity

2.0

116.1

1250

6042

127

Kela drug reimbursment

Transplant complication

3.3

115.4

451

1343

A02BC01

ATC

omeprazole; systemic

1.4

114.3

7147

53398

J96.1

ICD-10 Finland

Chronic respiratory failure

2.6

112.5

673

2534

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

112.5

1632

8724

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

112.4

1397

7101

J01FA06

ATC

roxithromycin; oral

1.3

112.1

9990

78846

128

Kela drug reimbursment

Cancers of female genital organs

3.0

112.1

508

1652

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

111.7

4028

27168

N05BA04

ATC

oxazepam; oral

1.4

111.6

6484

47817

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

110.8

4951

34828

A06AH03

ATC

naloxegol; oral

3.2

110.7

447

1358

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

110.7

1460

7569

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

109.7

9693

76341

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

109.5

1908

10777

ZXA00

NOMESCO Finland

Right side

1.4

109.2

6915

51699

ZXA05

NOMESCO Finland

Left side

1.4

108.6

6477

47937

SPAT1263

SPAT

Sampling

1.3

108.2

10409

82957

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

2.8

107.9

545

1882

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

105.2

1878

10676

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

105.0

900

3982

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

104.2

1947

11210

C07AB07

ATC

bisoprolol; oral

1.3

104.2

13251

109615

PH2BC

NOMESCO Finland

Extensive flebography of lower extremity with X-ray

43.5

102.8

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

8.3

102.7

136

158

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

102.6

1029

4842

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.0

102.4

1156

5679

A02BC05

ATC

esomeprazole; systemic

1.3

101.8

10281

82296

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

101.8

3723

25145

PH7FT

NOMESCO Finland

Inmplantation of filter to inferior vena cava with radiological guidance

133.3

101.6

110

N30.0

ICD-10 Finland

Acute cystitis

1.5

101.4

3955

27057

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.0

101.1

461

1504

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

101.0

1880

10809

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.8

100.5

504

1733

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.4

100.5

745

3099

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

100.2

4737

33598

R51.80

ICD-10 Finland

Headache

1.5

99.9

3373

22401

JN4CD

NOMESCO Finland

Very extensive body CT

2.1

99.3

999

4705

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

98.9

1000

4719

M10.9

ICD-10 Finland

Gout, unspecified

1.7

98.9

1831

10511

K07

ICPC

Swollen ankles/oedema

1.9

98.9

1270

6522

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

98.8

977

4572

67100

ICD-8 Finland

Puerperal phlebitis and thrombosis, Thrombophlebitis extremitatis inferioris

+∞

98.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

98.4

1577

8684

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.0

98.3

1158

5774

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

6.8

97.7

154

219

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

97.4

1626

9060

N06AX11

ATC

mirtazapine; oral

1.3

96.4

8279

64623

X58

ICD-10 Finland

Exposure to other specified factors

1.5

96.2

3185

21053

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

95.7

1639

9201

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

95.2

1436

7762

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

94.9

1755

10067

R4190

NOMESCO Finland

Nutritional therapy

2.2

92.8

843

3816

I50.0

ICD-10 Finland

Congestive heart failure

1.6

92.1

2171

13268

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

91.1

4386

31154

WX402

NOMESCO Finland

General anaesthesia

1.4

90.9

4827

34881

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

90.6

1077

5386

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

90.5

1417

7744

L04AX01

ATC

azathioprine; systemic

2.0

90.5

1012

4954

E0000UV, ,

ATC

1.3

90.0

10028

80958

P01AB01

ATC

metronidazole; oral, rectal

1.3

89.9

9582

76892

WX882

NOMESCO Finland

High dependency care

2.3

89.0

714

3073

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

87.7

4077

28756

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

87.6

1992

12060

N05BA01

ATC

diazepam; systemic, rectal

1.5

87.2

3193

21516

TK800

NOMESCO Finland

Hemodialysis

2.5

86.8

570

2244

45309

ICD-8 Finland

Other venous embolism and thrombosis, NUD (cerebri, cordis, mesenterii, pulmonis exceptis)

7.9

86.8

120

147

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

1.7

86.7

1676

9727

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

86.5

1712

9997

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

86.5

2673

17385

N06AB04

ATC

citalopram; systemic

1.4

86.2

5040

36973

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

85.7

1835

10940

J01AA02

ATC

doxycycline; systemic

1.3

85.4

20450

181430

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

85.4

1210

6411

J01EA01

ATC

trimethoprim; systemic

1.3

85.0

6439

49165

WF004

NOMESCO Finland

Palliative radiotherapy

2.4

84.8

586

2362

J46

ICD-10 Finland

Status asthmaticus

2.2

84.6

726

3212

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.7

84.4

468

1697

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

84.1

2841

18824

M54.5

ICD-10 Finland

Low back pain

1.3

83.1

8339

66203

TGC00

NOMESCO Finland

Bronchial lavation

2.2

82.9

687

2996

G47.3

ICD-10 Finland

Sleep apnoea

1.4

82.8

5261

39080

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

82.8

2569

16714

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

82.8

827

3883

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

82.7

609

2526

N06AX16

ATC

venlafaxine; oral

1.5

82.5

2979

20005

R07.3

ICD-10 Finland

Other chest pain

1.5

82.3

2474

15985

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

82.2

1867

11296

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

82.1

748

3390

UKC02

NOMESCO Finland

Cystoscopy

1.4

82.1

4195

30056

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

81.0

1117

5866

A01

ICPC

Pain general/multiple sites

1.6

81.0

2201

13900

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.8

80.4

411

1429

PH2AC

NOMESCO Finland

Flebography of lower extremity with X-ray

14.0

80.2

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

80.1

1722

10273

I27.0

ICD-10 Finland

Primary pulmonary hypertension

7.8

79.7

112

140

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

79.7

886

4327

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1.9

79.4

1086

5688

R03BA05

ATC

fluticasone; inhalant

1.4

79.2

4166

29978

GD1CQ

NOMESCO Finland

Lung circulation SPECT with low dose CT

11.3

79.0

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

2.7

79.0

433

1561

M05BX04

ATC

denosumab; parenteral

1.7

78.3

1518

8809

Z94.0

ICD-10 Finland

Kidney transplant status

3.3

78.3

306

912

K78

ICPC

Atrial fibrillation/flutter

1.6

78.1

2066

12961

R42

ICD-10 Finland

Dizziness and giddiness

1.3

77.8

5804

44120

PH7AC

NOMESCO Finland

Lumbal cavography with X-ray

42.2

77.6

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.8

77.6

1348

7589

C02KX04

ATC

macitentan; oral

18.5

77.5

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

76.9

1929

11949

W19

ICD-10 Finland

Unspecified fall

1.5

76.8

2388

15531

N05AH04

ATC

quetiapine; oral

1.4

76.7

3783

26909

C02KX05

ATC

riociguat; oral

734.6

76.3

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

76.0

4713

34815

A11CC03

ATC

alfacalcidol; systemic

2.3

75.9

614

2651

H02AB09

ATC

hydrocortisone; systemic

2.4

75.9

552

2277

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

75.9

5401

40751

R03DC03

ATC

montelukast; oral

1.4

75.9

3616

25560

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

75.7

1064

5620

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

75.6

1247

6915

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

75.4

769

3639

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

75.3

1529

8981

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

75.3

2999

20506

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

75.2

1980

12407

GAE40

NOMESCO Finland

Operation on rib and soft tissues for thoracic outlet syndrome

10.3

75.1

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

75.0

2680

17940

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.8

74.9

1182

6470

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

3.2

74.7

307

944

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

4.6

74.3

180

383

SPAT1216

SPAT

Assessment of functional ability

1.4

74.0

3983

28740

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

73.7

1287

7255

SPAT1301

SPAT

No procedures

1.3

73.4

7684

61119

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

73.3

9572

78271

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

72.9

2026

12849

L15

ICPC

Knee symptom/complaint

1.3

72.8

5495

41789

R52.0

ICD-10 Finland

Acute pain

2.1

72.3

749

3565

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

72.2

1263

7121

B03XA02

ATC

darbepoetin alfa; parenteral

2.3

71.8

541

2267

N05CD07

ATC

temazepam; oral

1.4

71.1

3112

21642

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.3

71.1

579

2508

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

71.0

1289

7345

45199

ICD-8 Finland

Phlebitis and thrombophlebitis, Of other and unspecified sites

+∞

70.9

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

70.9

2223

14473

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.5

70.7

2714

18412

PHM77

NOMESCO Finland

Endovenous obliteration of v.saphena parva

3.1

70.4

303

957

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

70.2

17156

150412

R55

ICD-10 Finland

Syncope and collapse

1.5

70.2

2798

19119

I82.21

ICD-10 Finland

Emboli and thrombosis in the inferior vena cava

16.0

70.0

SPAT1262

SPAT

Handing over of treatment supplies

1.4

69.9

4294

31626

M25.5

ICD-10 Finland

Pain in joint

1.3

69.9

7108

56255

XG466

NOMESCO Finland

Sleep oxymetry

2.0

69.7

760

3684

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.1

69.7

294

918

R03BA02

ATC

budesonide; inhalant

1.4

69.7

4078

29804

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

69.7

4770

35723

A07AA02

ATC

nystatin; oral

1.7

69.5

1460

8651

R03AC03

ATC

terbutaline; inhalant

1.4

69.3

3138

21951

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.0

69.2

309

997

PH1AT

NOMESCO Finland

Endovascular extension of superior vena cava and of arteries of upper extremity

20.1

68.9

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

68.8

3991

29121

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

68.6

6407

50121

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.8

68.4

360

1271

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

68.3

2589

17515

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.1

68.3

711

3390

J94.8

ICD-10 Finland

Other specified pleural conditions

2.4

68.2

460

1834

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

68.1

1688

10421

L04AD02

ATC

tacrolimus; systemic

3.3

67.7

258

758

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.1

67.5

685

3235

N18.8

ICD-10 Finland

Other chronic renal failure

2.1

67.5

662

3087

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

67.1

4580

34259

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

67.0

1535

9293

L16

ICPC

Ankle symptom/complaint

1.5

66.9

2428

16286

J01CA08

ATC

pivmecillinam; oral

1.3

66.7

9201

75502

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.4

66.7

240

680

SPAT1211

SPAT

Application of soft bandage

1.5

66.6

2043

13232

R06AE07

ATC

cetirizine; oral

1.3

66.3

10089

83706

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

66.3

2956

20614

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

65.9

9184

75421

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.9

65.6

793

3985

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

65.6

1064

5869

WW200

NOMESCO Finland

Immunization

2.1

65.6

635

2947

Z71.8

ICD-10 Finland

Other specified counselling

1.3

65.5

6805

53923

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.5

65.4

414

1603

JAH00

NOMESCO Finland

Laparotomy

2.0

65.3

688

3295

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

65.2

2998

21015

B01AF03

ATC

edoxaban; oral

2.2

64.8

592

2686

R5110, ,

SPAT

1.6

64.7

1584

9746

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.2

64.3

532

2319

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.9

64.3

824

4223

4549X

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

1.7

64.2

1244

7213

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

64.1

991

5389

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

63.8

679

3263

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

63.7

2854

19907

N06AA09

ATC

amitriptyline; systemic

1.5

63.4

2280

15254

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.0

63.4

660

3146

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

1.9

63.4

822

4229

R04.2

ICD-10 Finland

Haemoptysis

1.9

63.2

862

4508

A04

ICPC

Weakness/tiredness general

1.4

63.2

3384

24342

N05AA02

ATC

levomepromazine; systemic

1.8

63.2

897

4751

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.3

63.1

485

2050

N02BF02

ATC

pregabalin; oral

1.7

63.1

1288

7572

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

63.0

1896

12224

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

62.9

1135

6452

WX320

NOMESCO Finland

Spinalanesthesy

1.3

62.8

5800

45222

4512A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of lower extremities, unspecified

+∞

62.7

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

62.6

814

4191

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

3.0

62.6

289

951

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

62.6

922

4940

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

62.4

1691

10651

RS221, ,

NOMESCO Finland

2.7

62.3

351

1284

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

61.9

498

2146

A02BC03

ATC

lansoprazole; oral

1.3

61.9

7074

56646

M02AA07

ATC

piroxicam; topical

1.3

61.8

8976

73919

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.2

61.4

509

2221

FB1BC

NOMESCO Finland

Extensive angiography of arteria pulmonalis

13.3

61.3

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.0

61.3

278

906

PHD76

NOMESCO Finland

Resection of long saphenous vein

1.7

61.2

1090

6175

PH2ST

NOMESCO Finland

Endovascular thrombolysis of pelvic and lower leg veins with radiological guidance

127.8

60.9

J96.0

ICD-10 Finland

Acute respiratory failure

2.6

60.9

352

1304

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

1.8

60.7

896

4804

ZX108

NOMESCO Finland

Inhalation

3.5

60.6

209

576

RT360, ,

NOMESCO Finland

13.4

60.5

M01AH02

ATC

rofecoxib; oral

1.4

60.3

3117

22276

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

60.3

1078

6112

S06.0

ICD-10 Finland

Concussion

1.5

60.2

2388

16279

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

60.0

6057

47723

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

59.9

2216

14905

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.2

59.6

541

2448

FB1ST

NOMESCO Finland

Catheter-based therapy of pulmonary embolism

+∞

59.6

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

59.6

1053

5951

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

59.4

969

5352

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.4

59.4

409

1647

N05AH03

ATC

olanzapine; systemic

1.7

59.3

1214

7139

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.8

59.2

292

997

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.6

59.1

199

540

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

58.9

1750

11248

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.2

58.9

233

701

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.7

58.7

316

1130

WX872

NOMESCO Finland

Intensive care

1.7

58.7

1202

7071

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

58.6

4807

36835

M05BA04

ATC

alendronic acid; oral

1.5

58.6

2146

14400

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

58.6

9153

75866

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

58.6

9932

83055

GD1CN

NOMESCO Finland

Lung circulation isotope imaging

16.7

58.6

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.1

58.4

604

2873

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

58.3

6838

54856

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

58.0

599

2847

R4120

NOMESCO Finland

Occupational therapy

1.6

58.0

1447

8937

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

57.8

16106

141662

A12AA04

ATC

calcium carbonate; oral

2.4

57.6

399

1612

K29

ICPC

Cardiovascular sympt/complt other

1.7

57.5

1081

6214

A04AD12

ATC

aprepitant; systemic

2.2

57.5

477

2083

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.9

57.2

274

921

M01AX17

ATC

nimesulide; oral

1.3

57.0

5829

45955

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

57.0

514

2321

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.1

56.6

560

2620

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.2

56.6

232

713

J45.8

ICD-10 Finland

Mixed asthma

1.9

56.5

707

3595

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

56.5

2216

15067

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.0

56.2

252

816

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1.8

55.9

796

4221

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

55.8

692

3509

R03DA04

ATC

theophylline; systemic, rectal

1.6

55.6

1332

8149

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

55.5

782

4133

JAL30

NOMESCO Finland

Omentectomy

2.8

55.3

286

1002

K92.1

ICD-10 Finland

Melaena

1.6

55.1

1305

7961

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

55.0

2483

17322

L04AD01

ATC

ciclosporin; systemic

2.3

54.9

414

1737

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

54.8

1039

5987

J01CA04

ATC

amoxicillin; systemic

1.2

54.7

20384

184129

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

3.2

54.7

218

659

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

54.6

1394

8654

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

54.5

3249

23737

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

54.3

2543

17854

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

54.0

835

4541

R52.2

ICD-10 Finland

Other chronic pain

1.8

53.9

801

4303

S80.0

ICD-10 Finland

Contusion of knee

1.6

53.7

1510

9583

HA1AA

NOMESCO Finland

X-ray mammography

1.5

53.7

1643

10623

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

53.3

1434

9012

RT172, ,

NOMESCO Finland

8.9

53.3

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

5.3

53.1

108

198

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2.5

53.1

336

1302

T82

ICPC

Obesity

1.8

53.0

777

4156

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

53.0

1215

7351

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.0

52.7

614

3048

A41.8

ICD-10 Finland

Other specified sepsis

2.2

52.6

461

2058

ZXA10

NOMESCO Finland

Bilateral

1.3

52.5

4428

34003

FBB20

NOMESCO Finland

Thrombendarterectomy of pulmonary artery in chronic obstruction

+∞

52.4

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

5.3

52.4

107

197

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

52.2

517

2420

E86

ICD-10 Finland

Volume depletion

1.9

52.1

627

3148

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

2.7

52.0

289

1051

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.6

51.9

1284

7911

A02BA02

ATC

ranitidine; systemic

1.3

51.9

4691

36346

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

51.8

1853

12367

M79.1

ICD-10 Finland

Myalgia

1.4

51.8

2982

21654

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.8

51.8

793

4298

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.1

51.8

532

2525

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

51.7

800

4350

J45

ICD-10 Finland

Asthma

1.4

51.6

2195

15140

A29

ICPC

General symptom/complaint other

1.4

51.5

2884

20850

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

51.5

1953

13185

45198

ICD-8 Finland

Phlebitis and thrombophlebitis, Alia definita

+∞

51.4

M03BX02

ATC

tizanidine; oral

1.2

51.4

14611

128053

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

51.3

1651

10784

S76

ICPC

Skin infection other

1.6

51.1

1187

7206

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.4

51.0

366

1502

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

50.9

5803

46263

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.6

50.9

288

1057

N03AX09

ATC

lamotrigine; oral

1.8

50.9

858

4785

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

50.8

6263

50391

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

50.5

9055

75840

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

50.4

3038

22215

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

50.4

2266

15784

A07AA09

ATC

vancomycin; oral

2.4

50.4

364

1499

M48.0

ICD-10 Finland

Spinal stenosis

1.4

50.4

3015

22024

N06AX21

ATC

duloxetine; oral

1.4

50.1

2458

17382

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.1

50.0

493

2304

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

50.0

2887

20968

R31

ICD-10 Finland

Unspecified haematuria

1.4

49.9

2490

17657

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

49.8

2071

14221

N19

ICD-10 Finland

Unspecified kidney failure

1.7

49.5

879

4975

I81

ICD-10 Finland

Portal vein thrombosis

4.2

49.4

132

304

G44.2

ICD-10 Finland

Tension-type headache

1.4

49.3

2788

20180

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

49.3

2487

17670

B01AE07

ATC

dabigatran etexilate; oral

1.7

48.9

924

5317

TPX15

NOMESCO Finland

Removal of vascular injection port

3.9

48.8

143

353

R03AC13

ATC

formoterol; inhalant

1.6

48.5

1142

6954

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

48.5

671

3526

RT274, ,

NOMESCO Finland

7.1

48.5

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

48.4

4922

38668

RD210, ,

NOMESCO Finland

2.3

48.3

359

1497

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2.4

48.2

321

1274

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.6

48.1

1046

6244

PH7ZT

NOMESCO Finland

Intravenous removal of filter to inferior vena cava

102.6

48.0

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

48.0

1161

7116

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

47.9

546

2691

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.8

47.8

756

4137

WX722

NOMESCO Finland

PEEP

1.6

47.7

1045

6250

M66.0

ICD-10 Finland

Rupture of popliteal cyst

2.4

47.7

340

1392

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

47.6

611

3134

NF3AA

NOMESCO Finland

Femur X-ray examination

2.0

47.6

506

2433

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.9

47.5

595

3028

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

47.4

916

5303

GD1FN

NOMESCO Finland

Lung ventilation isotope imaging

12.6

47.4

L01BC59

ATC

trifluridine, combinations; systemic

4.7

47.3

110

227

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.0

47.1

501

2409

ZX112

NOMESCO Finland

Subcutaneous

2.0

47.0

497

2384

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

47.0

725

3939

SPAT1260

SPAT

Consultation of another employee

1.3

46.8

4030

30988

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

46.6

3730

28396

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.7

46.6

256

926

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.1

46.5

477

2263

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.1

46.4

468

2207

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.7

46.1

147

385

PH9AT

NOMESCO Finland

Expansion (PTA) of vein not elsewhere classified

83.9

46.1

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.5

46.1

1376

8844

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

46.0

2221

15656

WVA20

NOMESCO Finland

Medicine administration

1.9

45.6

569

2892

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.1

45.5

419

1909

L01BA01

ATC

methotrexate; systemic

1.7

45.4

815

4625

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.8

45.3

661

3531

M01AX05

ATC

glucosamine; oral

1.3

45.3

4739

37325

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

45.1

1222

7687

PHM99

NOMESCO Finland

Endovenous obliteration of other vein

2.1

45.1

441

2056

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

44.9

5719

46081

SPAT1234

SPAT

Support of social functional capacity

1.6

44.7

1210

7610

M01AH01

ATC

celecoxib; oral

1.3

44.6

4142

32138

N03AX14

ATC

levetiracetam; systemic

1.9

44.6

616

3235

J01MA06

ATC

norfloxacin; oral

1.3

44.6

2972

22041

C08CA01

ATC

amlodipine; oral

1.2

44.4

9667

82229

K28

ICPC

Limited function/disability (K)

1.9

44.2

543

2745

N18.0

ICD-10 Finland

End-stage renal disease

2.5

44.2

282

1098

S22.3

ICD-10 Finland

Fracture of rib

1.5

44.2

1571

10466

J01CF05

ATC

flucloxacillin; systemic

1.5

44.1

1250

7942

A12BA01

ATC

potassium chloride; oral

1.6

44.0

1111

6877

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.6

43.9

1090

6719

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.1

43.6

399

1814

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

43.5

1359

8817

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.7

43.1

823

4751

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

43.1

6247

51013

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

43.1

1425

9357

WX730

NOMESCO Finland

Conventional respirator

2.2

43.0

378

1691

R10.0

ICD-10 Finland

Acute abdomen

1.8

43.0

689

3786

R81

ICPC

Pneumonia

1.7

43.0

792

4528

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

42.9

1912

13283

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.8

42.8

611

3243

P01BA02

ATC

hydroxychloroquine; oral

1.4

42.7

1753

11999

N03AE01

ATC

clonazepam; systemic

1.5

42.7

1214

7718

L04AA01

ATC

[U] ciclosporin

2.3

42.7

328

1388

L04AX03

ATC

methotrexate; systemic

1.4

42.7

2017

14157

R07.1

ICD-10 Finland

Chest pain on breathing

2.2

42.7

347

1504

L03AA14

ATC

lipegfilgrastim; parenteral

2.1

42.6

402

1849

R03AC12

ATC

salmeterol; inhalant

1.6

42.6

1052

6479

J01FA10

ATC

azithromycin; systemic

1.2

42.6

12812

112055

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

42.5

1573

10560

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

42.5

1195

7581

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.2

42.4

168

507

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.6

42.2

243

901

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

41.9

2548

18626

SPAT1251

SPAT

Organisation of medication

1.7

41.9

810

4691

A10AB05

ATC

insulin aspart; parenteral

1.4

41.8

1649

11206

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

41.5

1567

10558

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.0

41.4

464

2273

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

41.4

16025

143055

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.5

41.4

1374

9027

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

2.8

41.4

208

719

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

41.4

831

4862

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

1.9

41.3

491

2455

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

2.5

41.1

270

1066

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.2

41.1

335

1454

R05

ICD-10 Finland

Cough

1.3

41.1

4666

37059

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

41.1

454

2214

SPAT1240

SPAT

Therapeutic discussion

1.4

41.0

1800

12472

R03BA01

ATC

beclometasone; inhalant

1.3

40.9

3126

23621

R96

ICPC

Asthma

1.4

40.8

2025

14328

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.5

40.8

257

995

J01DA09

ATC

[U] cefadroxil

1.2

40.8

5821

47409

R06.2

ICD-10 Finland

Wheezing

1.6

40.8

894

5348

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

40.8

2870

21437

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

1.8

40.7

626

3398

ZZA00

NOMESCO Finland

Split skin graft

1.8

40.7

648

3554

V03AE01

ATC

polystyrene sulfonate; oral

2.3

40.7

318

1356

R33

ICD-10 Finland

Retention of urine

1.4

40.4

1920

13484

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

2.5

40.4

266

1052

R18

ICD-10 Finland

Ascites

2.0

40.3

445

2169

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.0

40.2

463

2291

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.3

40.1

153

451

4518X

ICD-9 Finland

Phlebitis and thrombophlebitis, Of other sites

+∞

40.1

A03

ICPC

Fever

1.3

39.9

3106

23524

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

39.9

478

2398

A01AB09

ATC

miconazole; local oral

1.4

39.8

1924

13555

L02BG06

ATC

exemestane; oral

2.1

39.7

373

1713

FXA20

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure

8.0

39.7

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.3

39.7

298

1250

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.1

39.6

170

538

M09AX01

ATC

hyaluronic acid; parenteral

1.5

39.6

1140

7267

L01CA04

ATC

vinorelbine; systemic

2.6

39.6

223

818

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

39.6

4707

37567

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

39.5

4284

33826

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

39.4

1864

13080

K56.7

ICD-10 Finland

Ileus, unspecified

2.0

39.3

410

1958

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

39.3

589

3174

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.5

39.2

1083

6841

I82.1

ICD-10 Finland

Thrombophlebitis migrans

14.5

39.2

Z50.1

ICD-10 Finland

Other physical therapy

1.5

39.1

1167

7497

C56

ICD-10 Finland

Malignant neoplasm of ovary

3.2

39.1

155

468

ZX121

NOMESCO Finland

Central venous catheter

4.1

39.0

109

260

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.5

39.0

1393

9285

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

39.0

3052

23128

M01AE02

ATC

naproxen; oral, rectal

1.2

38.9

13045

114797

V03AE02

ATC

sevelamer; oral

3.4

38.8

142

408

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.3

38.7

2473

18208

N06AB10

ATC

escitalopram; oral

1.3

38.7

3969

31129

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.5

38.5

1295

8530

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

4.3

38.5

101

230

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

1.7

38.5

654

3657

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

38.3

1776

12417

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

38.3

985

6121

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.9

38.3

512

2662

SPAT1172

SPAT

Guidance concerning hydration

1.8

38.3

569

3059

N02AA01

ATC

morphine; systemic, rectal

2.0

38.2

413

1999

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.2

38.2

153

465

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

38.1

1859

13113

N07BC02

ATC

methadone; systemic

4.2

38.0

102

236

N03AG01

ATC

valproic acid; systemic, rectal

1.5

37.8

1171

7584

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

37.7

838

5031

X57

ICD-10 Finland

Unspecified privation

1.9

37.6

489

2521

N05AX12

ATC

aripiprazole; systemic

1.8

37.6

601

3302

ZY010

NOMESCO Finland

Hospital outpatient

1.6

37.6

861

5208

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.5

37.5

1155

7470

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.5

37.5

234

903

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

3.4

37.4

136

389

RS220, ,

NOMESCO Finland

2.3

37.4

272

1125

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.6

37.4

890

5434

A99

ICPC

Disease/condition unspecnature/site

1.4

37.3

1993

14266

I83

ICD-10 Finland

Varicose veins of lower extremities

1.8

37.3

519

2733

L02BA03

ATC

fulvestrant; parenteral

3.1

37.2

159

502

N05AX08

ATC

risperidone; systemic

1.4

37.2

1851

13096

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.9

37.1

449

2260

SPAT1125

SPAT

Stoma care and guidance

2.0

37.0

397

1917

E66

ICD-10 Finland

Obesity

1.6

36.8

907

5584

R04.0

ICD-10 Finland

Epistaxis

1.4

36.7

1714

12000

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.4

36.6

1502

10277

S29

ICPC

Skin symptom/complaint other

1.3

36.6

4200

33354

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

36.5

9727

83829

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

36.4

2445

18124

205

Kela drug reimbursment

Chronic hypertension

1.2

36.3

6906

57755

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

1.8

36.2

587

3238

J20

ICD-10 Finland

Acute bronchitis

1.4

36.2

2114

15348

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.5

36.2

1288

8579

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

36.1

2462

18287

L01AX03

ATC

temozolomide; systemic

2.9

36.1

167

552

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

36.1

1021

6484

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.6

36.1

831

5033

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.7

36.0

655

3732

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.5

36.0

1222

8063

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

35.9

902

5575

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.3

35.9

278

1182

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

35.8

2344

17309

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.3

35.8

2166

15808

J01FA09

ATC

clarithromycin; systemic

1.2

35.7

6695

55898

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

2.1

35.7

328

1494

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.1

35.7

355

1667

G04BD04

ATC

oxybutynin; oral, transdermal

1.5

35.7

1212

7997

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

1.8

35.5

502

2657

O22.8

ICD-10 Finland

Other venous complications in pregnancy

58.0

35.5

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.0

35.3

372

1784

PG1UT

NOMESCO Finland

Percutaneous aspiration throbectomy

3.5

35.3

123

343

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.8

35.2

536

2903

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.8

35.2

583

3237

N02AC04

ATC

dextropropoxyphene; oral

1.6

35.2

874

5390

E000001, ,

ATC

1.2

35.2

4200

33487

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

35.1

1705

12013

196

Kela drug reimbursment

Paricalcitol and cinacalcet

3.5

35.1

123

344

XF402

NOMESCO Finland

ECG with work load test

1.3

35.1

2373

17605

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.0

35.0

373

1797

K95

ICPC

Varicose veins of leg

2.1

34.9

343

1604

-50

ICPC

Medication/prescr/renewal

1.6

34.9

880

5446

E87.6

ICD-10 Finland

Hypokalaemia

1.6

34.9

732

4332

JN6AD

NOMESCO Finland

CT of torso and neck

2.1

34.9

350

1650

S01

ICPC

Pain/tenderness of skin

1.6

34.8

943

5932

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

34.8

1771

12578

KBV00

NOMESCO Finland

Insertion of stent into ureter

2.9

34.7

166

559

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.5

34.7

1053

6789

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.1

34.7

336

1563

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.3

34.6

276

1189

PHB76

NOMESCO Finland

Ligature of long saphenous vein

3.9

34.5

103

258

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019060) Gas panel - Arterial blood

3209

15249

2.16

322.61

5.2

4.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3388

16598

2.10

314.18

1.9

1.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2870

13175

2.23

314.08

7.9

6.5

24.83

24.80

mmol/l

0.15

2844

13040

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

409

466

8.58

313.47

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3882

20010

2.01

313.27

8.2

6.4

1.35

1.37

mmol/l

0.48

3774

19444

(3000991) Gas panel - Venous blood

3716

18903

2.03

310.99

9.7

7.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7163

37145

2.15

307.65

2.2

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4925

26569

1.95

307.65

4.7

4.0

253.48

244.16

u/l

3.48

4701

24959

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2137

5545

3.94

307.65

3.2

2.3

3.65

3.63

g/l

0.25

2040

5267

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6544

34881

2.05

307.65

3.0

1.9

30.62

29.86

12.34

6361

33811

(3006504) Eosinophils/100 leukocytes in Blood

14796

102890

1.80

307.65

7.9

5.9

2.69

2.87

18.97

14004

95566

(40760892) CBC W Ordered Manual Differential panel - Blood

14797

103146

1.79

307.65

8.5

6.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

12150

44806

3.80

307.65

2.4

1.6

1.98

1.14

mg/l

75.92

9950

34270

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

1504

1295

11.78

307.65

2.4

2.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

16861

117950

1.92

307.65

9.2

5.9

11.05

11.68

umol/l

8.25

16210

111586

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

3551

4878

7.88

307.65

2.3

2.1

96.41

88.90

55.49

3323

4716

(3022948) Iron [Moles/volume] in Serum or Plasma

6218

36508

1.82

307.65

3.0

2.5

11.76

12.80

umol/l

24.57

5830

33710

(3002582) Erythrocytes [#/volume] in Urine

10294

69542

1.67

307.65

4.3

3.2

97.78

97.68

e6/l

0.00

8155

53355

(3019198) Lymphocytes [#/volume] in Blood

15866

112704

1.80

307.65

7.7

5.7

1.82

1.91

e9/l

7.74

14057

98962

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5867

33775

1.85

307.65

3.0

2.4

2.27

2.31

g/l

5.44

5478

30983

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

15072

104531

1.82

307.65

8.6

5.7

1.21

mmol/l

14.12

14074

94584

(3027801) Oxygen [Partial pressure] in Arterial blood

5369

26206

2.20

307.65

8.0

6.8

11.56

12.30

kpa

20.99

5101

24943

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12842

88451

1.73

307.65

4.8

3.7

53.02

68.96

ng/l

0.53

9821

62724

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7346

44892

1.78

307.65

4.7

3.8

279.28

500.30

ng/l

4.71

6069

36048

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

861

696

12.28

307.65

1.2

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

14377

99962

1.78

307.65

6.8

4.6

33.84

35.27

g/l

154.10

13475

92214

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

871

786

11.00

307.65

1.2

1.1

1.09

1.07

ratio

1.39

299

271

(3034426) Prothrombin time (PT)

488

450

10.64

307.65

1.2

—

(3042936) Bacteria identified in Isolate by Culture

5742

31701

1.94

307.65

2.4

2.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5110

25444

2.14

307.65

2.1

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5288

29560

1.89

307.65

7.5

5.4

1.04

mmol/l

0.27

4970

27243

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

1841

1221

15.49

307.65

1.2

1.1

95.87

95.58

0.12

1679

1165

(3019069) Monocytes/100 leukocytes in Blood

14869

103468

1.80

307.65

8.3

6.2

8.69

0.01

14084

96238

(3022217) INR in Platelet poor plasma by Coagulation assay

18022

108571

2.62

307.65

25.2

15.3

1.38

1.29

inr

17.65

5349

30673

(3022096) Basophils/100 leukocytes in Blood

14455

99718

1.80

307.65

7.9

5.9

0.63

0.67

16.85

13667

92410

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5598

31703

1.88

307.65

3.1

2.5

20.91

22.36

11.12

4859

26764

(3013650) Neutrophils [#/volume] in Blood by Automated count

17577

127120

1.86

307.65

13.5

8.6

4.28

4.18

e9/l

5.93

15602

110313

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

16249

115331

1.83

307.65

9.8

6.4

1.21

mmol/l

10.56

13861

97340

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

2188

1925

11.80

307.65

1.3

1.2

3.92

3.66

u/ml

0.35

949

889

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5123

25406

2.15

307.65

2.1

1.7

—

(3006315) Basophils [#/volume] in Blood

15602

110051

1.81

307.65

7.6

5.6

0.04

e9/l

1.24

13551

94539

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

751

504

14.75

307.65

1.1

1.0

97.61

96.60

0.25

587

393

(3016502) Oxygen saturation in Arterial blood

4768

23478

2.15

307.65

8.4

7.1

95.11

95.59

5.40

4589

22592

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2936

4663

6.66

307.65

2.7

2.4

198.14

192.97

1.95

2721

4441

(3030467) Casts [#/volume] in Urine by Automated count

9537

63809

1.66

307.65

4.1

3.2

0.53

0.44

e6/l

1.81

7525

48673

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11484

68901

2.01

307.65

3.5

3.0

1527.39

1568.21

ng/l

0.33

10148

58960

(3023368) Bacteria identified in Blood by Culture

11485

62871

2.27

307.65

5.7

4.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5374

26222

2.20

307.65

8.0

6.8

5.07

5.09

kpa

0.57

5118

24958

(3018418) pH of Serum or Plasma

10312

68278

1.71

307.65

5.7

3.9

7.40

0.86

2321

12679

(3020779) Urea [Moles/volume] in Serum or Plasma

3988

20195

2.05

307.65

8.8

6.8

10.45

10.38

mmol/l

0.25

3777

19090

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

21447

174218

1.74

307.65

11.9

7.3

82.14

79.06

u/l

12.67

20574

163423

(3003396) Base excess in Arterial blood by calculation

5367

26217

2.20

307.65

8.0

6.8

1.23

1.06

mmol/l

2.36

4371

20869

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

443

479

9.05

307.65

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

17985

133166

1.81

307.65

6.9

4.6

6.77

6.79

mmol/l

0.56

17255

124837

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2306

1953

12.31

307.65

1.3

1.2

3.83

4.01

u/ml

0.10

750

714

(3033658) Prothrombin time (PT) actual/Normal

9830

56507

2.03

307.65

5.4

3.8

86.57

88.80

12.43

9479

55155

(3036489) Thrombin time

3770

6482

6.31

307.65

2.2

1.9

21.60

21.71

0.29

2990

5869

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4295

21543

2.09

307.65

9.0

7.5

120.99

120.91

g/l

0.08

4181

20971

(3001604) Monocytes [#/volume] in Blood

15567

109737

1.81

307.65

7.6

5.6

0.61

0.60

e9/l

4.39

13529

94325

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6825

36301

2.07

307.65

4.5

3.1

0.81

0.82

mmol/l

11.32

6458

33666

(3013115) Eosinophils [#/volume] in Blood

15908

113631

1.79

307.65

7.9

5.8

0.19

0.20

e9/l

10.61

14000

98905

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3457

6778

5.46

307.65

3.6

2.7

0.37

0.34

u/ml

6.17

2245

3681

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

2479

1631

15.97

307.65

1.1

119.54

117.31

1.53

2184

1492

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

2474

1740

14.93

307.65

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

14828

104312

1.77

307.65

7.7

5.8

59.02

57.68

32.46

14064

97177

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

548

675

7.97

307.65

1.2

1.1

22.34

9.44

u/ml

0.59

(3002030) Lymphocytes/100 leukocytes in Blood

15091

105964

1.79

307.65

8.0

6.0

25.76

27.29

50.95

14326

98800

(3018095) Leukocytes [#/volume] in Urine

11384

80427

1.61

305.99

5.0

3.7

116.57

107.55

e6/l

0.40

8542

57348

(36304419) Bacteria [Presence] in Urine

9184

61645

1.64

303.51

4.1

3.1

—

(3026008) Bacteria identified in Urine by Culture

10347

71548

1.62

303.16

3.9

3.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10280

71391

1.61

293.33

3.2

2.5

67.95

62.35

u/l

0.25

9633

65597

(3044640) Blood type and Crossmatch panel - Blood

10267

71403

1.60

290.46

3.1

2.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2607

11999

2.21

282.07

9.7

8.6

24.47

24.30

mmol/l

1.83

2506

11531

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3939

21154

1.92

279.70

4.8

3.7

5.88

5.82

kpa

2.82

3813

20523

(3002032) Base excess in Venous blood by calculation

3917

21119

1.92

274.45

4.8

3.7

2.06

1.89

mmol/l

2.07

3368

17926

(3031040) Bacteria [#/volume] in Urine by Automated count

18600

149302

1.58

273.82

6.2

4.6

1354.60

1518.87

e6/l

0.19

309

2194

(3012544) pH of Venous blood

4026

21973

1.89

271.55

4.8

3.7

7.39

7.38

0.19

149

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8590

57944

1.62

271.50

2.6

2.3

3.31

2.99

mg/l

19.85

7438

49106

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

13851

104570

1.54

265.17

3.2

2.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2809

13711

2.08

260.33

1.9

1.7

—

(3026782) Osmolality of Urine

7115

46254

1.65

258.73

3.8

2.9

528.59

541.19

mosm/kgh2o

5.47

6267

39523

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2107

9255

2.29

254.23

2.3

1.9

2.63

2.22

ug/l

0.25

1864

8072

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4297

24446

1.82

252.40

4.8

3.8

32.55

22.38

ug/l

1.28

3561

19966

(3000850) Epithelial cells [#/volume] in Urine

7363

48619

1.62

249.94

3.4

2.6

5.54

5.32

e6/l

0.81

6679

43448

(40758558) Short blood count panel - Blood

8232

55867

1.59

249.14

10.0

6.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2847

14199

2.04

248.27

4.4

3.5

5.16

5.15

kpa

0.12

2705

13359

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2745

13510

2.06

248.21

4.3

3.4

2.05

1.79

mmol/l

3.09

2095

9976

(3007853) Bacteria identified in Skin by Aerobe culture

4515

26224

1.79

246.96

2.1

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

10740

77581

1.54

245.79

4.8

3.3

2.35

mmol/l

8.60

9534

67273

(3009343) pH of Capillary blood

2813

14022

2.04

245.53

4.4

3.4

7.42

0.64

482

1766

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2871

14437

2.02

244.53

7.8

6.9

24.79

24.58

mmol/l

2.30

2732

13757

(3021589) Normoblasts [#/volume] in Blood

12862

96803

1.51

241.30

14.5

9.5

0.00

e9/l

0.95

10537

79234

(3014007) Fractional oxyhemoglobin in Arterial blood

2835

14409

2.00

233.78

10.1

8.5

93.39

93.85

3.45

2824

14356

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2821

14408

1.99

229.18

10.0

8.3

1.37

0.18

2799

14307

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2817

14381

1.99

229.15

10.1

8.4

0.66

0.67

0.68

2795

14289

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2661

13349

2.02

227.34

1.7

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1337

5009

2.65

227.23

1.8

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2482

12251

2.05

221.51

11.0

9.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9779

70529

1.51

218.31

4.2

3.1

34.45

34.77

u/l

0.16

9257

66530

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1283

4825

2.64

216.23

1.9

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7876

54358

1.55

214.95

3.0

2.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

18788

154886

1.49

212.12

5.9

4.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5672

36627

1.62

204.53

3.7

2.9

2.78

2.68

e6/l

0.30

3143

19995

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2158

10434

2.08

202.99

4.9

3.9

24.21

24.12

mmol/l

0.57

2106

10163

(3024354) Oxygen [Partial pressure] in Venous blood

3156

17375

1.85

202.91

4.0

3.1

4.61

4.52

kpa

1.23

3040

16774

(3020630) Protein [Mass/volume] in Serum or Plasma

3433

19399

1.81

202.68

3.0

2.5

65.15

66.49

g/l

19.23

3150

17431

(3027945) Reticulocytes/100 erythrocytes in Blood

4406

26731

1.70

202.53

3.1

2.3

1.91

1.76

14.95

3892

23378

(3010421) pH of Blood

1430

5853

2.43

201.50

4.9

3.8

7.42

0.87

1306

5338

(3027315) Oxygen [Partial pressure] in Blood

1299

5120

2.52

198.50

4.9

3.9

8.45

8.53

kpa

0.89

1272

4987

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

9669

70719

1.48

196.05

2.5

2.1

213.45

209.29

u/l

0.16

9119

65963

(40767503) Oxygen content in Capillary blood by calculation

1227

4737

2.57

195.76

2.9

2.5

16.13

16.22

0.30

641

2462

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

268

326

8.00

194.73

1.2

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3530

20354

1.77

194.02

3.2

2.9

201.62

225.18

ng/l

2.25

3227

18602

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4179

25305

1.70

192.57

3.3

2.6

9.38

8.98

umol/l

0.42

3637

21917

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5976

39560

1.58

192.49

3.4

2.8

1.31

1.23

e6/l

0.36

3429

22746

(3013290) Carbon dioxide [Partial pressure] in Blood

1278

5099

2.49

190.16

4.9

3.9

5.00

4.99

kpa

0.12

1251

4967

(3012501) Base excess in Blood by calculation

1277

5098

2.48

189.77

4.9

3.9

2.66

2.56

mmol/l

0.56

925

3452

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3512

20478

1.75

185.00

2.9

2.4

46.42

45.15

u/l

0.05

3026

17437

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1081

4044

2.64

183.73

7.0

5.2

3960.84

1407.96

iu/ml

0.36

194

590

(3001122) Ferritin [Mass/volume] in Serum or Plasma

12001

92372

1.44

182.19

3.5

2.8

164.66

138.75

ug/l

9.07

11098

84595

(3017181) Myelocytes/100 leukocytes in Blood

3237

18684

1.76

176.10

4.7

3.9

1.03

0.95

0.88

1498

6289

(1616796) Gas panel - Central venous blood

1234

5026

2.43

175.37

4.3

3.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3567

21215

1.71

174.21

2.4

2.2

0.20

0.21

g/l

4.60

3300

19611

(3026493) Urate [Moles/volume] in Serum or Plasma

8331

60272

1.47

173.40

3.4

2.6

4306.68

4904.36

umol/l

0.68

7245

52115

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

990

3651

2.68

173.02

1.9

1.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

956

3484

2.71

171.00

2.1

1.8

1.67

1.74

mmol/l

1.24

937

3403

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3821

23319

1.67

169.03

4.6

3.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3272

19229

1.73

166.36

2.5

2.2

363.87

376.84

nmol/l

2.79

3055

17561

(4035726) Immunohistochemistry procedure

3339

19782

1.71

164.75

1.5

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

2936

16978

1.75

157.61

4.6

3.8

0.78

0.68

1.06

1302

5407

(3023520) Reticulocytes [#/volume] in Blood

3331

19955

1.69

157.23

3.2

2.4

73.46

68.57

e9/l

10.77

2428

15231

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1656

7987

2.06

155.58

2.5

2.2

442.73

566.72

ug/l

0.86

1571

7494

(3021440) Promyelocytes/100 leukocytes in Blood

3029

17792

1.72

153.50

4.8

4.0

0.12

0.11

0.22

1303

5429

(3028626) Oxygen [Partial pressure] in Capillary blood

1166

4917

2.34

152.99

3.3

2.8

8.07

8.00

kpa

0.63

1139

4804

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6221

43370

1.49

152.37

4.2

3.0

2.47

2.46

mmol/l

16.84

5461

37687

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1295

5731

2.24

151.60

3.5

3.0

24.92

24.81

mmol/l

0.42

1268

5606

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

957

3704

2.55

151.44

1.6

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

787

2791

2.77

148.23

2.0

1.8

89.36

89.47

0.18

775

2751

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

833

3090

2.65

143.70

3.1

2.5

9820.37

6612.93

u/ml

0.14

175

(3013707) Erythrocyte sedimentation rate by Westergren method

19364

165502

1.40

143.07

5.3

4.1

15.57

12.84

mm/h

90.04

18081

152084

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

171

179

9.27

139.92

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1639

8175

1.99

139.91

3.9

3.3

6059.43

1392.81

u/ml

0.65

1384

6986

(3025159) Blasts/100 leukocytes in Blood

2837

16790

1.70

139.05

4.8

4.0

0.24

0.37

0.71

1110

4502

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1414

6699

2.09

139.02

1.4

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1849

9640

1.91

138.55

1.7

1.5

16.38

14.87

u/ml

0.16

236

(3005719) IgG [Mass/volume] in Serum or Plasma

2689

15756

1.71

136.59

3.6

2.6

10.15

10.68

g/l

7.10

2513

14323

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1394

6617

2.09

136.30

1.9

1.7

—

(3022313) Gas panel - Capillary blood

1913

10167

1.88

135.02

4.8

3.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

866

3377

2.52

134.79

1.9

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

866

3377

2.52

134.79

1.9

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

13515

109660

1.36

134.13

4.9

3.8

0.00

estimate

0.54

3207

21536

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

836

3222

2.55

133.34

1.6

1.3

—

(3021901) Oxygen saturation in Capillary blood

1000

4194

2.35

132.65

3.1

2.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

769

2854

2.65

132.47

1.7

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

669

2316

2.83

131.81

1.8

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

13486

109599

1.35

131.39

6.5

5.0

0.00

estimate

3.04

3026

20127

(3009261) Glucose [Presence] in Urine by Test strip

13615

110860

1.35

130.72

4.9

3.8

0.00

estimate

0.64

2962

19621

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

759

2818

2.64

130.63

1.6

1.3

—

(3019174) dRVVT (LA screen)

133

108

11.94

129.53

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1570

7939

1.96

128.58

2.8

2.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3076

18961

1.63

128.24

5.6

3.6

1.23

mmol/l

1.63

2792

16394

(3018405) Lactate [Moles/volume] in Arterial blood

1591

8105

1.95

127.48

4.4

4.1

1.38

1.39

mmol/l

0.19

1557

7959

(3044009) aPTT.lupus sensitive (LA screen)

131

109

11.65

125.63

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1110

4978

2.20

125.44

1.6

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2692

16182

1.67

123.61

2.8

2.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

767

2960

2.54

121.94

6.8

6.0

11.84

11.85

mg/l

0.03

703

2695

(3004119) Hemoglobin [Mass/volume] in Venous blood

2387

13969

1.71

121.10

4.3

3.2

125.61

128.41

g/l

7.47

2336

13630

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1958

10906

1.79

118.13

2.0

1.6

1.66

1.55

g/l

5.38

1705

9205

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

761

2971

2.51

118.07

1.6

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

871

3624

2.36

117.54

3.4

3.3

1.63

1.54

0.29

770

3197

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1086

5025

2.13

113.25

1.5

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1257

6142

2.02

113.23

1.8

1.6

0.24

0.23

g/l

3.08

1188

5791

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1085

5024

2.13

112.93

1.5

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1285

6349

2.00

112.18

1.8

1.6

1.21

1.18

g/l

2.78

1219

6016

(46235355) HIV 1 and 2 tests - Meaningful Use set

4266

29092

1.49

112.16

1.9

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1752

9604

1.81

111.30

6.2

4.8

1.64

0.05

1629

9029

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

24458

220751

1.47

110.78

27.2

14.6

26.54

24.71

mg/l

15.19

22217

176067

(3007930) Methemoglobin/Hemoglobin.total in Blood

1727

9448

1.81

110.42

6.3

4.9

0.88

0.89

0.25

1612

8874

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1627

8764

1.84

109.39

5.1

3.7

25.07

24.86

mmol/l

1.97

1512

8000

(3015736) pH of Urine

11005

88325

1.33

109.27

4.4

3.5

5.81

5.84

0.29

569

5621

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2798

17505

1.60

108.69

4.7

3.6

104.85

91.85

ng/l

8.09

2433

14847

(3030905) Polymorphonuclear cells [#/volume] in Blood

920

4072

2.22

107.24

3.6

3.2

4.24

4.22

e9/l

0.11

915

4064

(3017143) Hepatitis C virus Ab [Presence] in Serum

3240

21064

1.55

106.36

1.8

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1439

7522

1.89

106.28

1.7

1.6

237.36

249.21

titre

0.07

343

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1894

10791

1.74

105.27

3.6

2.7

1.25

1.24

0.35

1886

10734

(3028026) IgM [Mass/volume] in Serum or Plasma

2107

12367

1.70

105.12

2.2

1.9

1.22

1.36

g/l

2.16

1942

11164

(3021960) Folate [Moles/volume] in Serum or Plasma

7238

54873

1.37

103.82

1.7

1.5

19.29

20.48

nmol/l

9.29

6333

46560

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

11376

92235

1.32

103.16

2.6

2.2

76.57

1081.54

nmol/l

0.50

10242

81749

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1228

6147

1.97

103.15

1.7

1.4

15.34

14.64

iu/ml

0.07

131

(3037522) Nuclear Ab [Titer] in Serum

4144

28581

1.47

101.95

1.4

1.3

563.49

535.64

titre

0.40

894

6112

(3020891) Body temperature

1664

9226

1.79

101.52

5.4

4.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1084

5230

2.04

100.98

2.5

2.2

128.11

128.76

g/l

0.34

831

3743

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1843

10566

1.73

100.03

3.6

2.7

0.66

0.65

0.45

1837

10521

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3171

20882

1.52

97.54

2.5

2.4

6.82

7.15

ug/l

0.28

2689

17958

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

487

1682

2.83

96.36

1.7

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

934

4354

2.11

95.38

1.7

1.6

—

(3047181) Lactate [Moles/volume] in Blood

1354

7214

1.85

93.99

7.3

5.6

1.29

1.31

mmol/l

0.47

1198

6398

(3027273) Bicarbonate [Moles/volume] in Venous blood

1922

11363

1.68

92.92

4.5

3.4

25.36

25.22

mmol/l

0.95

1865

11040

(3000494) Fungus identified in Specimen by Culture

3741

25721

1.47

92.73

1.7

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

581

2251

2.52

91.57

1.7

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

581

2252

2.52

91.49

1.7

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

6153

46227

1.36

91.42

1.9

1.8

1166.70

1163.82

nmol/l

0.08

4753

34475

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1606

9084

1.75

91.22

2.5

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1607

9098

1.75

90.97

2.5

2.2

7.55

7.43

g/l

1.95

1453

8071

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1602

9069

1.75

90.71

2.5

2.2

3.78

3.72

g/l

0.82

1452

8048

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1794

10480

1.70

90.66

5.0

3.9

48.68

47.71

0.91

1776

10361

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

451

1546

2.85

90.51

1.8

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

980

4748

2.03

90.16

3.9

3.1

1941.74

676.57

u/ml

1.51

887

4318

(3043409) Potassium [Moles/volume] in Arterial blood

1316

7044

1.84

89.95

4.7

4.3

3.90

3.89

mmol/l

0.16

1303

6984

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3623

24976

1.46

88.20

1.8

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1385

7617

1.79

86.54

4.1

3.1

59.30

67.00

mg/l

0.36

1099

6172

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1381

7605

1.79

85.90

4.1

3.1

47.83

43.50

mg/l

0.19

1092

6162

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

409

1369

2.91

85.76

1.3

1.4

12.98

12.94

umol/l

0.04

387

1291

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1350

7390

1.80

85.67

4.0

3.1

9.76

3.33

ratio

0.55

566

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1503

8490

1.75

85.65

2.5

2.2

10.06

10.24

g/l

0.85

1337

7414

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1387

7675

1.78

84.86

2.8

2.4

1.06

0.96

g/l

0.35

1190

6476

(3003434) Protein [Mass/volume] in Pleural fluid

730

3238

2.21

84.56

1.4

1.5

33.56

32.27

g/l

1.89

662

2900

(40761536) Microorganisms panel - Urine sediment

2802

18507

1.51

84.21

5.4

4.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1499

8516

1.74

83.67

2.6

2.2

3.05

2.95

g/l

3.53

1348

7489

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1655

9764

1.68

80.32

2.4

1.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

11648

96813

1.27

80.10

2.2

2.0

93.11

95.43

pmol/l

5.98

6523

49922

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1231

6702

1.81

79.45

2.5

2.2

0.02

0.04

g/l

0.54

1129

6065

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1058

5534

1.88

77.64

3.8

2.8

1.83

1.60

mg/l

10.00

970

5015

(3013512) EKG study

8471

67895

1.29

77.16

4.8

4.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

352

1162

2.95

75.71

1.8

1.4

—

(3039000) Anion gap in Blood

987

5090

1.90

75.64

8.2

6.5

11.10

11.19

mmol/l

0.33

883

4592

(3018572) Chloride [Moles/volume] in Blood

987

5091

1.90

75.60

8.3

6.5

105.25

105.01

mmol/l

0.89

883

4593

(3023183) Ammonium ion [Moles/volume] in Plasma

928

4691

1.94

75.52

2.7

2.6

31.90

33.79

umol/l

1.73

839

4186

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

348

1155

2.93

74.14

1.8

1.4

—

(3045788) Cell count panel - Pleural fluid

532

2185

2.38

73.88

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1518

8959

1.67

73.42

2.1

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

646

2889

2.19

73.31

1.5

3263.18

2655.84

e6/l

0.24

466

2102

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1141

6231

1.80

72.82

2.5

2.3

0.00

g/l

2.32

1041

5620

(3052851) Hemolysis interference index of Serum or Plasma

1250

7014

1.75

72.71

3.9

3.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

381

1344

2.76

72.52

1.7

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1252

7044

1.75

72.14

2.4

2.2

36.46

37.57

g/l

8.25

1095

5999

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1124

6140

1.80

71.66

2.5

2.3

0.00

g/l

-0.00

1040

5601

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1741

10724

1.60

70.93

5.4

3.3

89.87

57.81

u/ml

2.28

1675

10336

(3011397) Hemoglobin [Presence] in Urine by Test strip

6694

52520

1.30

70.45

4.5

3.7

—

(3012441) Differential panel - Pleural fluid

572

2484

2.25

69.77

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

751

3630

2.02

69.46

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

1895

11980

1.56

69.02

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

713

3400

2.05

68.45

1.4

1.2

284.63

281.95

u/ml

0.08

481

2145

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

16209

141473

1.24

67.86

3.9

3.0

60.39

50.64

u/l

20.98

15128

130609

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

780

3853

1.98

67.86

1.6

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

964

5126

1.84

67.09

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

718

3465

2.03

66.70

2.6

2.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

515

2186

2.30

66.34

1.3

1.4

6.06

6.40

mmol/l

1.76

478

2019

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

998

5383

1.82

66.31

1.7

1.6

—

(3024928) Oxygen saturation in Venous blood

897

4690

1.87

65.84

3.8

3.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2089

13643

1.52

65.47

1.5

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

584

2632

2.17

65.02

1.4

1.5

55395.44

56258.34

e6/l

0.03

349

1579

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

519

2233

2.27

64.75

1.9

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

1040

5720

1.78

64.74

4.4

3.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

710

3456

2.01

64.40

1.6

1.4

111.00

117.37

u/ml

0.98

169

789

(3026250) Tacrolimus [Mass/volume] in Blood

264

815

3.15

63.85

39.2

32.8

7.25

7.30

ug/l

0.16

247

724

(3042631) Mycobacterium sp identified in Specimen

672

3226

2.04

63.34

2.5

2.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

761

3837

1.94

62.37

1.6

1.4

13.97

22.35

u/ml

—

(3019977) pH of Arterial blood

344

1246

2.69

62.27

2.7

2.4

7.43

7.42

1.39

136

441

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

487

2085

2.28

61.49

2.0

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

14465

125435

1.23

61.32

3.1

2.7

—

(40768806) Pleura Pathology biopsy report

553

2508

2.15

60.61

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

7406

59783

1.26

60.28

5.4

4.2

0.00

estimate

0.14

2867

19247

(3044889) 12 lead EKG panel

17768

157557

1.23

60.22

4.6

3.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

451

1894

2.32

59.59

1.9

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

451

1894

2.32

59.59

1.9

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

451

1894

2.32

59.59

1.9

1.6

—

(40768804) Tissue Pathology biopsy report

10786

90907

1.23

59.36

2.3

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

5063

39024

1.31

59.26

1.8

1.4

2.51

2.53

g/l

0.19

3172

22953

(40768797) Stomach Pathology biopsy report

4162

31223

1.34

59.02

1.3

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

352

1330

2.57

58.57

2.0

—

(3011412) CD3 cells [#/volume] in Blood

445

1875

2.31

58.36

2.3

1.35

1.14

e9/l

0.48

405

1700

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

610

2920

2.04

57.97

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

482

2117

2.22

57.25

1.7

1.5

44.63

23.84

iu/ml

1.30

(3037121) Protein [Mass/volume] in Urine

1291

7782

1.63

57.23

4.1

2.9

0.35

0.31

g/l

0.52

668

3196

(3010375) cycloSPORINE [Mass/volume] in Blood

261

869

2.92

55.41

32.3

27.1

113.36

113.17

ug/l

0.02

221

727

(3041096) Erythrocytes [Presence] in Urine by Automated

7147

57944

1.25

55.01

4.7

3.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

501

2287

2.14

54.04

3.6

3.3

59.99

56.98

2.42

429

1899

(3008757) Leukocyte morphology finding [Identifier] in Blood

528

2463

2.09

53.82

4.3

3.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

393

1630

2.35

53.48

2.0

2.1

38.15

38.37

0.09

384

1597

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

10011

84429

1.22

52.83

5.3

4.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

353

1405

2.44

52.67

2.0

1.9

15.06

16.19

1.10

344

1361

(1175426) CD3 cells/100 lymphocytes in Blood

356

1439

2.41

51.35

2.0

1.9

72.82

71.90

0.47

345

1367

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1058

6283

1.65

49.70

1.6

0.24

9.75

iu/ml

2.21

254

1423

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

477

2224

2.09

48.72

1.3

491.49

473.68

u/l

0.08

444

2107

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

404

1775

2.21

48.02

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

579

2914

1.94

47.75

1.9

1.8

23.27

24.72

ug/l

0.27

569

2844

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

283

1064

2.58

47.66

1.9

2.0

100.69

96.65

1.03

257

997

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

461

2143

2.09

47.47

3.1

2.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

923

5365

1.68

47.08

1.3

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1411

9087

1.53

46.84

2.0

1.9

38.13

39.05

u/l

0.84

1251

7899

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

478

2266

2.05

46.71

3.8

3.7

—

(3037756) Immunofixation for Serum or Plasma

882

5082

1.70

46.49

1.9

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

292

1131

2.51

46.25

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

413

1861

2.16

46.11

2.5

2.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

24721

229459

1.29

45.76

29.8

17.1

139.51

139.64

mmol/l

14.08

24357

223383

(3022145) Colonoscopy Study observation

3343

25141

1.32

45.57

1.4

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

338

1412

2.33

45.32

1.3

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

291

1137

2.49

45.26

2.2

1.8

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

351

1497

2.28

44.85

1.2

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

290

1138

2.48

44.69

2.2

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

273

1042

2.54

44.61

2.3

1.9

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

350

1495

2.28

44.56

1.2

1.1

—

(3017569) Oxygen content in Arterial blood

269

1020

2.56

44.56

2.4

2.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

350

1496

2.27

44.49

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

688

3744

1.79

44.38

1.8

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

348

1486

2.28

44.34

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

348

1486

2.28

44.34

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

347

1484

2.27

44.06

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

242

884

2.66

43.24

2.4

1.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

388

1751

2.16

43.18

1.3

11.88

13.65

u/l

1.48

349

1620

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1085

6716

1.58

42.97

1.5

1.4

255.83

267.63

ug/g

1.07

646

3929

(3021788) Differential panel - Synovial fluid

748

4211

1.73

42.91

1.6

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

643

3467

1.81

42.78

4.6

3.4

42.54

37.60

u/ml

0.42

623

3353

(3000012) Reticulocyte production index

631

3386

1.82

42.65

2.9

2.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

24738

230011

1.28

42.45

30.0

17.2

3.99

3.98

mmol/l

17.63

24354

223524

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

378

1708

2.15

41.95

1.5

1.4

12.13

13.15

u/l

1.88

359

1650

(3010503) CD19 cells [#/volume] in Blood

300

1231

2.37

41.94

2.3

2.5

0.28

0.37

e9/l

0.26

292

1187

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

237

873

2.64

41.67

2.4

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

237

873

2.64

41.67

2.4

1.9

—

(3002385) Erythrocyte distribution width [Ratio]

20607

188076

1.20

41.47

30.7

17.3

15.40

15.13

7.30

20350

184563

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

488

2433

1.95

41.43

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

172

5.01

41.35

1.2

—

(3035880) pH of Pleural fluid

311

1305

2.32

41.32

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

1785

12368

1.42

40.63

1.4

1.3

201.58

246.09

u/ml

1.33

1642

11403

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

146

416

3.40

40.40

1.5

1.2

139.25

16.48

mg/l

1.35

102

317

(3035637) Corticotropin [Mass/volume] in Plasma

496

2510

1.92

40.31

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

612

3324

1.79

39.76

1.6

0.75

0.80

g/l

0.43

462

2493

(3042733) HLA Ab [Presence] in Serum

183

614

2.89

38.49

5.0

4.8

—

(40768446) Kidney Pathology biopsy report

208

750

2.69

38.20

1.8

1.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

766

4487

1.67

37.96

1.4

1.2

227.50

112.56

titre

0.52

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

821

4897

1.64

37.90

1.5

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

635

3536

1.75

37.89

1.6

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

704

4042

1.70

37.63

4.3

3.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

495

2562

1.88

37.59

3.0

2.3

1.13

1.23

g/24h

0.41

276

1206

(3045142) Bone marrow Pathology biopsy report

476

2438

1.90

37.33

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

510

2674

1.86

37.20

19.6

8.0

7.47

7.49

mmol/l

0.03

440

2183

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

197

701

2.73

37.13

1.9

1.7

11310.66

40318.96

u/ml

0.76

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

183

627

2.83

37.06

1.9

—

(4200892) Spirometry reversibility

2242

16371

1.35

36.98

1.5

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1004

6330

1.55

36.67

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

207

761

2.64

36.61

1.9

2.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

914

5645

1.58

36.54

1.7

1.6

15387.94

14177.08

e6/l

0.28

636

4101

(3037692) Legionella sp identified in Specimen by Organism specific culture

206

760

2.63

36.18

1.5

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4568

36680

1.24

35.94

1.3

39.12

37.39

iu/ml

0.14

1443

11727

(42529406) Shigella sp [Presence] in Stool by Culture

1002

6343

1.54

35.93

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

548

2986

1.79

35.26

2.9

2.0

32.41

32.59

0.42

537

2967

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

989

6280

1.54

34.98

1.2

—

(3000492) Spirometry study

2681

20246

1.31

34.89

1.6

1.5

—

(3044941) Cell count panel - Synovial fluid

628

3574

1.71

34.70

1.6

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

171

586

2.83

34.65

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

428

2176

1.91

34.37

4.4

3.7

75.17

46.49

u/ml

1.70

422

2142

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1238

8268

1.47

34.28

1.3

1.2

0.82

0.93

u/ml

0.16

119

764

(3003694) ABO and Rh group [Type] in Blood

6850

57500

1.20

34.23

1.5

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

183

658

2.70

33.86

1.1

—

(3004451) EKG impression Narrative

265

1134

2.27

33.73

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

3182

24671

1.28

33.70

2.5

2.2

165.97

139.25

ug/g

3.23

2575

19194

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

352

1684

2.03

33.69

1.2

90.00

145.69

titre

0.72

(4062490) Immunoglobulin typing, IgG

412

2083

1.92

33.65

1.5

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

352

1688

2.03

33.48

1.2

182.50

166.69

titre

0.16

299

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

892

5599

1.56

33.24

1.4

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1002

6452

1.52

33.21

1.9

1.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

411

2088

1.91

33.10

1.5

1.4

6.44

6.94

g/l

1.81

288

1447

(3024139) IgG subclass 3 [Mass/volume] in Serum

410

2087

1.91

32.83

1.5

1.4

0.37

0.43

g/l

1.77

287

1450

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6006

49978

1.20

32.75

1.7

19899216.36

31043892.88

pmol/l

0.95

4940

40730

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

360

1755

1.99

32.71

2.4

1.7

4.08

3.96

mg/l

0.19

344

1660

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

848

5284

1.57

32.64

1.3

9.24

5.76

u/ml

0.38

102

548

(3028192) IgG subclass 2 [Mass/volume] in Serum

409

2089

1.90

32.42

1.5

1.4

2.72

2.97

g/l

1.90

288

1447

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

175

630

2.69

32.33

1.1

—

(3002256) Pathology report gross observation

3742

29733

1.25

32.03

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

212

843

2.44

31.92

1.9

179.02

151.14

4.07

194

785

(3017732) Neutrophils [#/volume] in Blood

2065

15221

1.33

31.82

3.7

2.9

5.00

5.11

e9/l

0.14

1615

11898

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

970

6262

1.51

31.77

1.5

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

854

5363

1.55

31.76

1.3

8.64

6.88

u/ml

0.37

155

850

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2441

18431

1.30

31.66

3.7

2.6

60.88

63.73

ml/min/173m2

2.44

1123

7427

(3008536) Aspergillus sp Ab [Presence] in Serum

129

403

3.10

30.86

2.5

2.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1713

12343

1.36

30.65

3.8

2.7

0.38

0.28

e6/l

1.17

1668

12050

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

526

2953

1.73

30.58

2.5

2.6

105.96

911.61

u/ml

1.68

516

2914

(3016650) Hepatitis A virus Ab [Presence] in Serum

561

3206

1.70

30.58

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.93

30.20

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

304

1443

2.05

29.80

2.4

2.5

805.39

662.40

e6/l

0.39

286

1387

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

178

675

2.56

29.67

2.5

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

178

675

2.56

29.67

2.5

2.4

—

(3024932) HLA-DR beta [Type]

166

609

2.64

29.59

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

900

5811

1.51

29.47

2.0

11.78

11.32

mg/l

0.77

831

5361

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

22465

208470

1.19

29.46

24.1

13.8

77.00

78.27

ml/min/173m2

14.01

19768

172233

(3001964) Herpes simplex virus Ag [Presence] in Specimen

161

583

2.68

29.45

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

900

5813

1.51

29.42

1.3

36.39

41.00

u/ml

0.20

350

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4249

34506

1.22

29.39

1.3

16.19

12.80

u/ml

0.88

1506

12979

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

161

584

2.67

29.36

1.1

88.80

87.51

0.17

265

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

168

624

2.61

29.22

1.9

2.0

213.43

174.29

3.21

159

585

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

323

1583

1.98

28.97

1.3

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

217

914

2.30

28.76

3.3

4.4

719.66

1439.28

mg/l

0.41

169

628

(3024471) HLA-A [Type]

167

625

2.59

28.62

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

283

1333

2.06

28.35

2.4

655.42

503.55

e6/l

0.57

231

1138

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

717

4455

1.57

27.98

1.2

5.63

12.27

u/ml

0.61

(3013727) Leukocytes other/100 leukocytes in Blood

181

714

2.46

27.80

3.6

3.5

56.62

52.90

1.53

175

689

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

714

4442

1.57

27.72

1.3

1.2

8.46

4.66

u/ml

0.45

336

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

845

5457

1.51

27.65

1.2

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

237

1055

2.18

27.51

3.2

3.4

—

(3019225) pH of Specimen

3000

23636

1.25

27.39

6.2

4.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

462

2584

1.74

27.27

3.4

3.3

9.42

8.67

nmol/l

0.10

444

2511

(3051651) Icteric interference index of Serum or Plasma

283

1354

2.03

27.19

4.9

3.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

272

1284

2.06

27.12

2.5

0.23

0.24

e9/l

0.23

233

1134

(40762365) Oxygen content in Arterial blood by calculation

117

374

3.03

26.98

2.8

2.7

14.92

14.84

ml/dl

0.10

109

345

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

251

1154

2.11

26.85

2.7

37.24

39.13

0.72

136

667

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

312

1555

1.95

26.70

1.5

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

820

5327

1.50

26.10

4.1

3.2

1.54

1.62

mmol/l

1.73

805

5217

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

245

1130

2.10

26.01

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

245

1130

2.10

26.01

1.6

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

233

1056

2.14

25.88

2.5

2.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

18347

168236

1.15

25.70

4.4

4.0

14.96

14.87

pmol/l

4.96

16764

151724

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

305

1530

1.93

25.63

1.5

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

177

720

2.38

25.47

1.3

1.2

0.55

0.52

g/l

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

510

2988

1.66

25.39

5.3

4.7

352.75

358.87

umol/l

0.36

431

2542

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

381

2064

1.79

25.15

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

203

883

2.23

25.00

1.7

1.9

137.40

115.54

umol/l

0.32

102

470

(21494755) Public health laboratory ask at order entry panel

1278

16558

0.73

24.87

1.3

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1763

13152

1.31

24.82

3.1

3.3

4.32

4.42

pmol/l

4.25

1540

11624

(3034770) Mitochondria Ab [Titer] in Serum

869

5776

1.47

24.69

1.2

1060.00

994.68

titre

0.09

186

(21494890) Protein electrophoresis panel - 24 hour Urine

437

2477

1.71

24.64

2.5

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

276

3.26

24.32

4.6

5.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

233

1091

2.07

23.81

1.1

5.05

4.05

iu/ml

0.27

(3038515) Glucose [Moles/volume] in Venous blood

773

5060

1.49

23.73

4.2

3.3

7.42

7.68

mmol/l

1.87

758

4965

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

213

974

2.12

23.19

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

239

1146

2.02

22.92

3.4

3.8

—

(40761535) Cells panel - Urine sediment

2490

19584

1.25

22.90

4.5

3.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

542

3310

1.59

22.86

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

279

1414

1.91

22.81

1.8

1.7

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

149

594

2.43

22.48

1.2

1.1

103.64

107.80

0.62

137

540

(3045716) Anion gap in Serum or Plasma

218

1020

2.07

22.36

2.6

2.4

9.55

9.83

mmol/l

0.59

213

994

(3009508) Creatinine [Moles/volume] in Urine

8265

72373

1.14

22.00

3.7

3.2

7.27

7.40

mmol/l

1.86

6876

60342

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

284

3.10

21.95

2.1

2.0

—

(3051611) Lipemic interference index of Serum or Plasma

424

2462

1.67

21.92

4.4

3.3

—

(3035285) Chloride [Moles/volume] in Venous blood

508

3090

1.60

21.81

2.9

2.4

105.74

105.54

mmol/l

0.44

503

3066

(3041354) Potassium [Moles/volume] in Venous blood

508

3090

1.60

21.81

2.9

2.4

4.03

4.09

mmol/l

2.19

503

3067

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2887

23201

1.22

21.66

2.0

1.7

1.55

1.49

3.89

2447

20109

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

194

883

2.13

21.42

2.8

2.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

411

2382

1.68

21.41

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

144

579

2.41

21.35

1.1

86.04

87.48

0.17

266

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

376

2132

1.71

21.25

1.2

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

492

2989

1.60

21.25

1.6

1.4

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

101

341

2.87

21.24

2.7

1073.74

1769.47

u/l

0.41

302

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

697

4573

1.48

21.20

1.5

1.4

265.60

147.65

pmol/l

2.97

680

4450

(3025468) Yersinia sp identified in Specimen by Organism specific culture

478

2886

1.61

21.19

1.6

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

326

2.91

21.17

1.3

—

(3000330) Specific gravity of Urine by Test strip

1572

11807

1.30

21.02

4.6

3.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

578

3654

1.54

20.99

1.3

49.25

36.02

u/l

0.98

510

3138

(3033705) Calcium.ionized [Moles/volume] in Venous blood

499

3051

1.59

20.99

3.0

2.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

272

1406

1.88

20.98

1.5

1.3

1.95

1.36

u/ml

0.50

159

799

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

602

3844

1.52

20.88

1.3

1.2

—

(4281824) Cell count and differential, peritoneal fluid

403

2340

1.67

20.86

1.2

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

190

869

2.12

20.74

1.3

1.4

64.79

63.19

0.25

153

706

(3024522) Salmonella sp identified in Specimen by Organism specific culture

481

2925

1.60

20.71

1.6

1.4

—

(40757373) Influenza virus identified in Isolate

119

444

2.59

20.68

1.6

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

476

2892

1.60

20.57

1.6

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

384

2212

1.69

20.49

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

476

2896

1.60

20.45

1.6

1.4

—

(3045414) Leukocytes [Presence] in Urine

1358

10034

1.32

20.45

2.1

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

357

2018

1.72

20.43

1.6

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

475

2894

1.59

20.30

1.6

1.5

56.82

59.65

0.79

301

1823

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

478

2917

1.59

20.28

1.6

1.4

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

167

733

2.21

20.23

1.3

1.4

2.40

2.64

0.15

144

606

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

283

3.01

20.20

5.8

4.8

66.55

42.16

ug/min

2.09

228

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

266

1386

1.86

20.04

2.1

1.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

670

4420

1.47

19.85

2.3

2.1

5230.99

4736.48

u/l

0.16

252

1678

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

307

2.90

19.80

2.9

2.5

101.79

71.17

mg/l

—

(3012565) Volume of 24 hour Urine

220

1089

1.96

19.37

2.4

2.1

1847.75

1953.07

0.85

200

945

(3003181) Sodium [Moles/volume] in Urine

637

4186

1.48

19.26

1.4

1.3

63.63

61.93

mmol/l

0.48

494

3332

(3007566) Smooth muscle Ab [Titer] in Serum

843

5836

1.41

19.26

1.2

105.86

131.97

titre

0.76

524

(40768441) Liver Pathology biopsy report

286

1550

1.79

19.00

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

639

4214

1.47

18.99

1.3

1.2

42.32

44.31

u/ml

0.12

423

(3004716) Salmonella sp identified in Stool by Organism specific culture

1297

9627

1.32

18.92

1.3

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

637

4202

1.47

18.90

1.6

1.3

—

(3012516) Albumin [Mass/volume] in Urine

7905

69555

1.13

18.89

3.6

3.2

612.14

396.57

mg/l

2.89

5196

44004

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

109

410

2.57

18.68

1.3

1.2

110.76

109.06

0.14

394

(3014271) Vancomycin [Susceptibility]

256

1349

1.84

18.65

3.3

3.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

153

672

2.20

18.55

2.1

2.0

9.63

10.34

0.25

139

615

(3039162) Centromere protein B Ab [Units/volume] in Serum

431

2624

1.60

18.52

1.2

54.20

53.03

u/ml

0.03

181

(3028707) Methadone [Presence] in Urine by Screen method

373

2193

1.65

18.46

5.4

2.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

163

736

2.15

18.45

1.3

3.69

3.43

mmol/l

0.47

145

677

(3000093) Morphology [Interpretation] in Blood Narrative

379

2242

1.64

18.32

1.2

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

270

2.94

18.11

1.3

1.4

66.98

75.66

1.57

221

(40757494) Bilirubin.total [Moles/volume] in Blood

236

1226

1.87

18.01

2.3

2.1

17.03

26.15

umol/l

1.00

118

(3049717) Cytology report of Urine Cyto stain

1282

9575

1.31

17.87

2.6

2.8

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

414

2519

1.60

17.85

2.2

2.0

1.67

7.11

titre

—

(3020682) Albumin/Creatinine [Ratio] in Urine

8289

73353

1.13

17.83

4.2

3.8

12.84

8.88

mg/mmol

8.86

5315

45859

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

666

4499

1.44

17.49

1.6

1.4

1420.88

2721.05

e6/l

0.65

555

3683

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1323

16262

0.78

17.48

1.7

1.8

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

324

2.72

17.42

12.5

10.6

5.53

5.36

mmol/l

0.18

324

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

748

5164

1.41

17.40

1.2

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

150

672

2.16

17.35

2.1

1.9

29.58

29.13

0.12

141

630

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

215

1102

1.89

17.13

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

215

1103

1.89

17.09

1.4

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

663

4497

1.43

17.04

1.6

1.3

28.53

32.51

e6/l

0.16

527

3488

(3011288) Drugs identified in Urine by Screen method

512

3302

1.51

17.03

6.7

2.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5221

44964

1.15

16.94

1.3

1.41

1.69

u/ml

1.39

1377

11725

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

815

10661

0.73

16.83

1.4

—

(3019150) Specific gravity of Urine by Refractometry

5617

48650

1.14

16.74

5.4

4.2

1.02

kg/l

0.28

844

7483

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

787

5522

1.39

16.66

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

131

568

2.23

16.46

1.4

26.79

20.87

1.34

102

473

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

128

551

2.25

16.36

7.5

5.5

70.28

70.14

0.02

106

431

(3009214) Lutropin [Units/volume] in Serum or Plasma

676

4655

1.41

15.99

1.5

1.3

12.14

11.17

u/l

0.89

555

3766

(3042517) Benzodiazepines panel - Urine

145

3.53

15.87

2.9

2.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

213

3.04

15.79

1.2

90.00

106.65

ug/l

0.39

136

(3006576) Bicarbonate [Moles/volume] in Blood

171

835

1.98

15.77

5.5

6.4

25.03

24.96

mmol/l

0.08

160

749

(3000919) Neutrophils/100 leukocytes in Pleural fluid

144

662

2.11

15.65

1.3

1.4

20.99

20.40

0.09

134

591

(3014891) Appearance of Pleural fluid

338

2.58

15.56

1.3

—

(3036180) Methadone [Presence] in Urine

139

635

2.12

15.37

4.0

2.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

735

5173

1.38

15.31

1.4

1.3

590.09

546.92

mg/l

0.73

709

4904

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

186

946

1.90

15.24

13.3

11.6

911.62

817.32

nmol/l

1.57

179

902

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

446

2867

1.51

15.13

1.8

1.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

396

2.42

15.01

1.3

1.1

95.00

81.51

2.05

120

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

289

2.68

14.96

1.4

1.3

553.40

168.31

u/l

0.40

204

(3013005) Retinol [Moles/volume] in Serum or Plasma

154

739

2.02

14.94

1.8

1.7

2.05

2.00

umol/l

0.30

145

690

(3000060) B lymphocytes [#/volume] in Blood

109

457

2.31

14.87

1.9

2.0

112.26

876.73

e6/l

1.52

248

(3003327) Ova and parasites identified in Stool by Light microscopy

924

6773

1.33

14.79

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

400

2.39

14.69

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

139

3.48

14.64

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

354

2181

1.57

14.58

1.7

1.5

31.29

28.75

0.59

214

1346

(21494434) Karyotype in Bone marrow

326

1975

1.60

14.43

1.2

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

190

994

1.85

14.30

18.2

16.4

1538.67

2381.39

nmol/l

0.42

182

954

(1761868) Lipid panel - Serum or Plasma

6971

73200

0.89

14.13

3.1

3.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

326

2.52

14.12

1.3

1.2

1.26

1.39

mmol/l

0.09

197

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

232

1303

1.73

13.78

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

188

996

1.83

13.62

13.5

12.4

0.64

0.63

mmol/l

0.07

176

915

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

232

1310

1.72

13.53

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

285

1699

1.63

13.51

1.2

73.29

78.52

u/ml

0.09

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

646

4549

1.38

13.47

1.3

1.2

3.82

3.80

mmol/l

0.20

601

4262

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

399

2.33

13.42

1.2

87.31

69.07

2.66

120

(40768795) Lymph node Pathology biopsy report

350

2195

1.55

13.38

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

285

1705

1.62

13.33

1.2

40.70

45.05

u/ml

0.11

137

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

356

2256

1.53

12.99

1.2

1.1

2.14

1.96

iu/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

124

580

2.07

12.97

1.4

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

272

1622

1.63

12.90

1.2

15.51

7.53

u/ml

0.25

102

(3047189) Immunofixation for 24 hour Urine

194

1056

1.78

12.89

2.0

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

123

576

2.07

12.83

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

430

2841

1.47

12.83

1.1

1.52

1.53

g/l

0.05

399

2552

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

229

2.74

12.82

9.2

6.9

0.38

0.43

umol/l

0.23

201

(40761511) CBC panel - Blood by Automated count

24111

227989

1.13

12.75

23.9

13.9

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

230

2.73

12.72

2.7

3.2

1.41

1.12

mg/l

0.37

174

(3036603) Volume of Urine

253

1489

1.65

12.66

1.5

1900.32

1895.23

0.04

247

1440

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

252

1483

1.65

12.61

3.5

3.4

143.42

139.96

nmol/l

0.04

246

1464

(3020393) Adenovirus Ag [Presence] in Stool

194

2.89

12.59

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

428

2838

1.46

12.54

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

224

1284

1.69

12.41

1.9

2.61

2.57

u/field

0.02

158

892

(3008295) Osmolality of Serum or Plasma

346

2205

1.52

12.33

1.4

280.42

277.38

mosm/kgh2o

1.44

271

1687

(3006922) Hepatitis E virus Ab [Presence] in Serum

242

1419

1.65

12.30

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

533

3694

1.40

12.27

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

799

5903

1.32

12.17

2.9

2.6

—

(3016750) Collection duration of Urine

231

1344

1.67

12.11

2.5

2.1

498.43

499.43

min

0.05

168

989

(40768443) Skin Pathology biopsy report

1305

10252

1.24

12.07

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

277

1690

1.59

12.00

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

165

876

1.82

11.95

1.4

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

458

3108

1.43

11.90

1.3

0.17

0.26

nmol/l

1.61

225

(3003129) Base excess in Capillary blood by calculation

121

580

2.02

11.89

1.9

1.8

0.84

0.62

mmol/l

0.20

112

549

(3011985) Renin [Units/volume] in Plasma

438

2949

1.44

11.87

1.5

1.4

60.63

58.51

mu/l

0.09

395

2595

(3022621) pH of Urine by Test strip

1844

15029

1.20

11.80

3.5

3.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

468

3194

1.42

11.78

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

120

576

2.02

11.75

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

311

1961

1.54

11.67

2.2

2.1

2.58

2.34

u/field

0.21

132

781

(3034891) Synovial lining cells/100 cells in Synovial fluid

194

1088

1.73

11.67

1.5

4.02

3.80

0.05

235

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

381

2507

1.47

11.65

1.2

62.38

60.59

u/l

0.21

349

2236

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

456

3105

1.42

11.63

1.3

1.54

1.74

nmol/l

0.07

442

2972

(3038026) Centromere Ab [Units/volume] in Serum

284

1757

1.57

11.61

1.3

1.2

59.54

51.71

u/ml

0.13

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

103

470

2.12

11.55

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

511

3557

1.39

11.50

1.4

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

210

2.72

11.46

2.0

1.6

50.76

44.96

umol/l

0.64

210

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

22497

222030

0.90

11.37

5.2

5.1

2.68

2.71

mmol/l

6.81

20533

203357

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

337

2.32

11.37

1.4

1.2

144.44

360.64

ng/l

0.42

222

(3020564) Creatinine [Moles/volume] in Serum or Plasma

24698

234182

1.13

11.36

30.3

17.2

83.55

79.06

umol/l

45.13

24693

234076

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

114

3.39

11.36

5.2

5.1

—

(3017704) Immunofixation for Urine

222

1301

1.65

11.35

1.8

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

848

6380

1.29

11.31

5.5

4.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

21797

215443

0.90

11.26

4.7

4.5

1.41

1.46

mmol/l

73.95

19883

197082

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.84

11.23

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

21557

202938

1.10

11.17

5.3

4.8

2.04

2.12

mu/l

0.35

19829

184294

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

500

3488

1.39

11.12

1.2

—

(3044927) Protein electrophoresis panel - Urine

371

2458

1.46

10.99

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

194

1108

1.70

10.96

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

266

2.47

10.95

2.1

2.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

198

1139

1.68

10.89

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

326

2109

1.50

10.88

1.5

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

127

3.20

10.88

1.1

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

123

613

1.94

10.87

2.2

1.9

55.72

34.29

u/l

0.51

111

559

(3019832) Treponema pallidum Ab [Presence] in Serum

1530

12366

1.21

10.72

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

153

822

1.80

10.71

1.8

1.9

2086.40

2701.65

e6/l

0.16

572

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

22009

217273

0.91

10.57

4.7

4.6

4.56

4.62

mmol/l

12.77

20210

199931

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

272

2.42

10.46

3.8

2.9

39.89

40.05

umol/l

0.02

224

(3020191) Ethanol [Moles/volume] in Serum or Plasma

261

1626

1.56

10.40

1.5

1.4

1.19

1.32

promille

0.74

203

1231

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

331

2175

1.48

10.26

1.8

2301.54

2579.34

titre

0.08

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

252

2.46

10.19

2.2

2.1

—

(3024263) Appearance of Synovial fluid

205

1212

1.64

10.19

1.5

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

555

4004

1.35

10.05

1.8

4.84

5.02

mmol/24h

0.55

486

3481

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

101

484

2.02

10.01

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

234

1436

1.58

9.98

1.3

1.2

97.25

91.31

u/l

0.46

211

1246

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

141

756

1.80

9.98

1.6

1.5

3070155.56

2256845.28

iu/ml

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

351

2.20

9.97

1.5

1.6

102.69

112.55

ug/l

0.41

291

(3021387) Prolactin [Units/volume] in Serum or Plasma

705

5273

1.30

9.89

1.8

1.7

312.49

304.45

mu/l

0.23

641

4790

(3007463) Buprenorphine [Presence] in Urine

5.22

9.89

5.8

7.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

353

2.19

9.84

1.7

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

536

3862

1.35

9.80

4.3

2.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

204

1220

1.62

9.71

1.2

206.97

336.41

u/l

2.38

191

1127

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

399

2749

1.41

9.62

1.4

1.3

362.21

333.30

pmol/l

0.17

347

2360

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

408

2822

1.40

9.62

1.1

—

(3044007) Cell count panel - Peritoneal fluid

124

647

1.85

9.60

1.8

1.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

479

2.00

9.58

1.2

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

309

2.25

9.48

1.3

44.14

40.89

mg/l

0.23

257

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

227

1401

1.57

9.48

1.3

1.2

30.00

25.26

u/l

0.65

204

1189

(3004616) Nuclear Ab [Presence] in Serum

390

2687

1.41

9.42

1.3

—

(3002619) Bacteria identified in Specimen by Culture

457

2.01

9.35

1.4

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

108

545

1.92

9.27

1.6

0.37

0.38

ug/l

0.07

340

(3004775) Volume in Urine collected for unspecified duration

289

1889

1.48

9.26

2.4

2.2

741.30

666.04

1.57

198

1260

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

168

969

1.68

9.24

1.5

1.2

53.30

61.66

0.47

102

(3052592) Norovirus Ag [Presence] in Stool

474

1.98

9.15

1.3

—

(3042951) Complement C1q Ab [Units/volume] in Serum

3.54

9.12

1.1

1.2

35.03

13.78

u/ml

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

122

646

1.83

9.04

3.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

491

1.95

8.96

2.3

—

(3016018) Differential panel - Cerebral spinal fluid

328

2212

1.44

8.95

1.7

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

133

726

1.77

8.92

1.8

19179.35

9653.91

e6/l

0.61

399

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

113

3.08

8.83

1.5

1.6

5.44

4.09

mg/l

0.38

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

113

3.08

8.83

1.5

1.6

2.73

2.60

mg/l

0.05

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

113

3.08

8.83

1.5

1.6

0.46

1.39

mg/l

1.07

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

113

3.08

8.83

1.5

1.6

0.94

1.00

mg/l

0.04

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

113

3.08

8.83

1.5

1.6

1.14

3.30

mg/l

2.05

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

113

3.08

8.83

1.5

1.6

1.00

2.01

mg/l

1.47

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

113

3.08

8.83

1.5

1.6

2.65

1.92

mg/l

0.24

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

113

3.08

8.83

1.5

1.6

2.19

2.47

mg/l

0.13

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

113

3.08

8.83

1.5

1.6

2.14

1.82

mg/l

0.13

(3041918) Cholesterol [Moles/volume] in Pleural fluid

443

1.99

8.70

1.3

1.2

1.99

1.54

mmol/l

2.89

263

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

202

1240

1.58

8.68

1.7

1.4

6.08

6.09

u/l

0.00

178

1035

(3002621) Streptococcal DNAse B [Units/volume] in Serum

168

2.65

8.60

1.1

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

395

2774

1.38

8.56

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

104

533

1.89

8.56

2.3

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3614

31630

1.12

8.56

1.5

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

174

1034

1.63

8.56

1.4

1.5

7.27

8.97

ug/l

1.34

160

938

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

568

1.86

8.53

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1583

13105

1.18

8.50

1.2

114.90

141.64

iu/ml

2.18

520

4902

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

276

1824

1.47

8.41

1.6

25.52

25.46

u/ml

0.01

382

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

175

1047

1.62

8.39

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

222

2.40

8.38

1.1

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.49

8.36

3.0

3.7

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

506

1.89

8.24

1.2

1.4

29.73

40.81

g/l

0.44

383

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

118

2.95

8.23

1.5

1.6

1.58

2.20

mg/l

0.35

(3028433) Virus identified in Specimen by Culture

130

724

1.74

8.18

1.2

1.1

—

(36660697) Celiac disease serology panel - Serum

1930

16274

1.16

8.17

1.2

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

129

2.85

8.16

1.2

1.1

1.19

1.14

u/field

0.14

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

156

2.66

8.16

2.1

2.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.80

8.11

11.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

227

1454

1.51

8.09

1.7

1.6

4.13

7.17

u/l

4.39

180

1168

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

300

2.16

8.03

1.3

1.4

7.41

227498.17

nmol/l

1.67

251

(3034274) Bile acid [Moles/volume] in Serum --fasting

254

1670

1.47

7.98

1.8

1.9

7.99

9.45

umol/l

0.47

201

1204

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1838

15480

1.16

7.92

2.4

2.1

10.93

12.37

nmol/l

11.74

1602

13691

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

413

2963

1.35

7.87

1.1

13.06

12.02

au/ml

0.09

155

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

246

1613

1.48

7.84

1.3

2.29

2.16

mmol/l

0.67

230

1487

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

368

2.02

7.80

1.3

1.4

11.45

11.12

0.04

175

(3033799) Differential panel - Peritoneal fluid

127

713

1.72

7.79

2.0

1.9

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

177

1083

1.58

7.77

2.6

2.4

219.12

205.79

u/l

0.98

177

1073

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

128

2.79

7.70

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

123

687

1.73

7.69

1.3

1.2

0.33

0.31

g/l

2.64

105

549

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

24639

234445

1.10

7.66

16.4

10.4

26.32

25.88

u/l

1.94

24027

225207

(3016879) Cocaine [Presence] in Urine

618

4708

1.27

7.62

4.1

2.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

203

2.38

7.56

2.9

1.6

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

386

1.98

7.54

1.1

2.90

8.64

pmol/l

0.58

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

115

634

1.75

7.54

1.3

1.2

113.98

111.97

0.33

104

555

(3046861) Legionella sp Ag [Presence] in Urine

119

2.84

7.52

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

932

7447

1.22

7.46

1.4

1.3

30.76

31.51

iu/l

0.28

787

6443

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

211

2.34

7.40

1.2

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

106

574

1.79

7.39

1.3

1.4

15.40

13.47

g/l

1.19

442

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1543

12896

1.16

7.38

2.6

2.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

124

703

1.71

7.37

1.2

1.3

448.55

273.86

ug/l

0.36

386

(3009871) Measles virus Ab [Titer] in Serum

118

660

1.73

7.36

1.6

1.7

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

403

1.94

7.35

1.4

1.3

84.25

216.28

titre

1.00

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

105

569

1.78

7.31

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

112

619

1.75

7.29

2.0

1.8

—

(3028300) Cannabinoids [Presence] in Urine

661

5108

1.26

7.25

3.9

1.9

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

111

2.87

7.24

1.8

1.4

23.83

22.94

mmol/l

0.55

(3016038) Potassium [Moles/volume] in Urine

231

1522

1.47

7.23

1.2

1.1

33.78

35.14

mmol/l

0.35

197

1278

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

106

2.92

7.22

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

467

1.86

7.21

7.5

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

161

2.52

7.19

2.1

2.3

16.91

21.16

mg/l

1.34

149

(3000764) Benzodiazepines [Presence] in Urine

655

5062

1.26

7.18

3.9

1.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

356

1.98

7.04

3.3

2.8

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.53

7.02

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.44

7.02

1.7

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

420

3076

1.32

7.02

2.4

2.1

30.54

26.56

mg/l

0.57

118

810

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

207

1343

1.49

7.01

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

267

1821

1.42

6.97

1.1

—

(3027008) Opiates [Presence] in Urine

656

5094

1.25

6.92

3.6

1.9

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

131

2.66

6.85

1.2

1.1

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

3.69

6.84

1.2

1.0

1.24

1.11

u/field

0.29

(3036071) Salmonella sp Ab [Titer] in Serum

102

561

1.76

6.79

1.1

—

(40763590) HLA-DQ beta [Type]

3.54

6.77

1.0

—

(46236302) HLA-C [Type] by High resolution typing

3.54

6.77

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

179

1136

1.52

6.75

1.8

1.5

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

283

2.08

6.75

2.1

2.7

111.46

69.17

pmol/l

0.55

246

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

316

2232

1.37

6.73

1.1

—

(3023410) Appearance of Cerebral spinal fluid

287

2006

1.39

6.53

1.8

1.5

—

(40765096) Chromosome analysis panel by Banding

112

640

1.69

6.53

1.2

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

118

2.70

6.51

1.6

207.50

195.67

ng/l

0.29

105

(3027944) Amphetamines [Presence] in Urine

641

5006

1.24

6.45

3.8

1.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

653

5113

1.24

6.42

1.6

1.8

33.69

12.41

iu/l

0.50

216

1766

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1706

14513

1.14

6.42

2.4

20.47

25.14

au/ml

1.06

106

1050

(44786800) Granulocytes/100 leukocytes in Body fluid

315

1.99

6.42

1.2

1.3

23.84

25.27

0.12

246

(3020961) Endomysium IgA Ab [Titer] in Serum

1116

9199

1.18

6.40

1.1

157.83

217.80

titre

0.53

225

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

552

1.73

6.32

7.7

7.8

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

146

900

1.57

6.31

3.1

2.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

145

893

1.57

6.29

1.8

1.6

3.98

6.67

nmol/l

0.48

123

755

(3016244) Insulin [Units/volume] in Serum or Plasma

158

993

1.54

6.27

3.1

3.2

35.02

26.37

mu/l

1.09

144

931

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

224

1514

1.43

6.20

1.3

67.50

59.92

titre

0.14

133

(3051593) INR in Capillary blood by Coagulation assay

188

1231

1.48

6.15

11.9

10.4

—

(40760409) HLA-A [Type] by High resolution

3.38

6.05

1.0

—

(40760410) HLA-B [Type] by High resolution

3.38

6.05

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

532

1.73

5.99

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

277

2.02

5.99

1.3

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

170

1097

1.50

5.99

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

165

2.34

5.92

1.5

1.2

0.74

1.12

ml/s/173m2

1.28

105

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

386

1.85

5.92

5.3

4.8

42.38

67.07

u/l

1.57

375

(3001019) Free T4 and TSH panel - Serum or Plasma

779

8993

0.83

5.90

1.6

1.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

238

1642

1.40

5.90

3.2

2.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

228

1563

1.41

5.87

1.3

483.33

418.41

titre

0.11

126

(3034988) Calcium [Moles/volume] in Capillary blood

402

1.83

5.82

1.8

1.7

1.18

mmol/l

0.01

383

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

537

1.71

5.81

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

495

1.74

5.77

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

539

1.70

5.74

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

109

643

1.64

5.69

1.4

1.2

35.70

21.47

0.89

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.83

5.66

1.7

1.3

—

(3047185) IgG [Mass/volume] in Urine

3.73

5.65

1.1

—

38.67

—

(3013862) HLA-DP [Type]

3.22

5.63

1.0

—

(3045424) Erythrocytes [Presence] in Urine

497

3837

1.26

5.61

1.7

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

536

1.70

5.59

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

339

1.88

5.56

2.0

1.7

59.88

50.96

pmol/l

0.18

279

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

215

1474

1.41

5.56

1.2

1.1

44.05

45.06

mg/l

0.09

189

1226

(3051387) C reactive protein [Mass/volume] in Capillary blood

632

5026

1.22

5.43

4.7

3.4

29.99

27.54

mg/l

0.89

426

3200

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.96

5.39

1.0

—

(3008898) HLA-B27 [Presence]

744

6015

1.20

5.39

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

420

1.77

5.37

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

199

2.14

5.28

1.1

1.0

—

2.00

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

480

1.71

5.26

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

21213

208235

0.94

5.25

4.2

4.1

1.38

1.29

mmol/l

51.71

19194

188868

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.74

5.13

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

551

1.65

5.08

1.3

1.2

120.53

130.32

nmol/l

0.24

399

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

204

1412

1.40

5.04

1.1

305.90

288.52

mg/l

0.24

184

1236

(3006969) Lambda light chains [Mass/volume] in Urine

3.28

4.99

1.1

1.0

0.13

0.03

g/l

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

271

1967

1.33

4.97

1.3

1.56

1.42

nmol/l

1.22

245

1781

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

237

2.00

4.95

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

137

884

1.50

4.91

2.2

2.1

76.12

321.40

ug/l

1.10

128

842

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1739

15082

1.12

4.87

1.9

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

252

1.96

4.86

1.1

21.74

18.70

u/l

0.41

169

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1534

13214

1.13

4.82

1.3

43.29

53.85

au/ml

0.93

714

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

547

4345

1.22

4.81

2.3

1.7

0.95

0.82

nmol/l

3.95

469

3603

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

188

2.11

4.79

4.8

2.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

157

2.22

4.76

1.3

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

174

1189

1.42

4.66

1.1

10.10

8.70

iu/ml

0.28

269

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

168

1142

1.42

4.64

1.2

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

936

7828

1.16

4.58

1.7

1.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

129

2.32

4.57

5.4

8.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

524

1.62

4.52

1.3

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

233

1.95

4.47

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1561

13528

1.12

4.46

1.8

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

113

2.39

4.42

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

310

1.81

4.40

2.3

2.0

15.64

16.87

umol/l

0.39

310

(3010144) Erythrocytes [#/volume] in Synovial fluid

300

2255

1.29

4.33

1.5

1.4

191102.15

122545.73

e6/l

0.72

203

1561

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.55

4.32

1.0

0.24

0.06

u/ml

0.45

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

592

1.57

4.29

1.2

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

7.24

4.24

2.1

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

300

1.80

4.23

1.2

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

104

2.42

4.20

1.1

20.02

21.68

0.92

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

104

2.42

4.20

1.0

1.1

7.70

8.80

1.22

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

104

2.42

4.20

1.1

37.65

36.63

0.73

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

365

1.72

4.19

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

574

1.57

4.15

2.2

1.9

8.11

9.16

mg/l

1.19

460

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

228

1662

1.33

4.14

1.3

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

131

871

1.45

4.12

2.1

2.3

51.94

52.35

umol/l

0.04

107

731

(3013293) Extractable nuclear Ab [Presence] in Serum

317

1.77

4.11

1.5

1.6

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.59

4.10

1.0

0.12

0.03

u/ml

0.57

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

155

2.12

4.08

1.0

1.1

12.79

10.09

u/l

0.21

155

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

181

2.03

4.07

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

164

1139

1.39

4.06

1.5

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

133

890

1.45

4.05

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

137

924

1.43

4.01

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

590

4811

1.19

4.00

1.3

208.59

221.58

miu/ml

0.34

201

2073

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

131

2.21

4.00

1.3

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

189

1.99

3.99

2.0

2.1

0.59

0.98

mmol/l

1.36

118

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.60

3.95

2.4

1.4

88.13

141.53

ug/l

1.20

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

301

1.77

3.90

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

301

1.77

3.90

1.3

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

632

5197

1.18

3.90

3.3

3.1

0.78

0.81

nmol/l

1.02

479

4016

(3036670) Protein [Mass/volume] in Synovial fluid

112

731

1.48

3.89

1.3

40.01

39.78

g/l

0.05

387

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

240

1.85

3.82

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

190

1367

1.34

3.81

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

239

1778

1.30

3.79

1.2

—

titre

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

171

1212

1.36

3.78

1.2

1.1

33.58

24.85

u/l

1.08

160

1077

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

171

1212

1.36

3.78

1.2

1.1

89.62

85.37

u/l

0.31

159

1083

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

483

5566

0.84

3.75

1.4

1.5

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.92

3.71

1.1

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

299

2296

1.26

3.70

1.4

0.35

0.34

nmol/l

0.07

208

1722

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

979

8352

1.14

3.68

1.1

16.07

6.83

u/ml

0.26

124

(3030313) Adrenal Ab [Titer] in Serum

143

2.09

3.64

1.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

124

2.18

3.64

1.2

—

(40758292) HTLV I+II Ab panel - Serum

301

1.73

3.63

1.6

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

301

1.73

3.63

1.3

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

118

2.21

3.62

1.6

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

187

1356

1.33

3.58

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

627

1.50

3.57

3.0

2.3

147.27

148.97

nmol/l

0.06

541

(3048879) Bone marrow aspiration report

108

715

1.46

3.54

1.8

1.7

—

(40768793) Breast Pathology biopsy report

588

4851

1.17

3.53

1.3

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.44

3.52

1.2

1.1

1.00

1.31

u/field

0.36

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

226

1.84

3.51

1.0

0.01

0.53

u/ml

1.65

144

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

276

1.75

3.49

1.5

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

146

1024

1.38

3.48

1.1

1.04

1.10

u/l

0.65

492

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

156

1106

1.36

3.47

1.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

102

2.27

3.44

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

134

930

1.39

3.40

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

201

1.87

3.40

1.7

1.2

24.63

520.95

mg/24h

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

113

763

1.43

3.36

1.2

—

(3028468) Fragments [Presence] in Blood by Light microscopy

6.76

3.27

3.1

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

111

2.18

3.26

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

150

1071

1.35

3.23

1.2

1.3

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.88

3.19

2.1

1.5

149.11

218.50

nmol/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

106

2.19

3.17

1.5

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.79

3.16

1.6

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

566

1.49

3.15

4.9

2.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

235

1.77

3.14

1.1

—

(44813793) Dust mix specific IgE antibody measurement

189

1404

1.30

3.11

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.53

3.07

1.3

1.4

585.62

483.40

nmol/l

0.26

(42529582) MDA5 Ab [Presence] in Serum by Line blot

540

1.49

3.02

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

540

1.49

3.02

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

540

1.49

3.02

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

540

1.49

3.02

1.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

597

1.46

2.98

1.5

2.3

0.97

1.03

ug/l

0.14

564

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

106

725

1.41

2.98

1.3

1.4

14.92

15.63

pmol/l

0.76

598

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

114

790

1.40

2.98

3.6

2.9

29.19

28.50

umol/l

0.31

599

(1002224) Polysomnography panel

917

7908

1.12

2.97

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

261

1.70

2.97

1.6

1.3

293.33

105.06

titre

—

(3035933) Granulocytes/100 leukocytes in Blood

449

1.53

2.96

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

394

4515

0.84

2.96

1.5

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

344

1.60

2.91

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

2.32

2.90

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

317

2525

1.21

2.89

1.5

1.3

28.87

31.40

u/l

0.69

275

2048

(3050794) Legionella sp Ab [Presence] in Serum

178

1.85

2.87

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

308

1.63

2.87

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

240

1858

1.25

2.87

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

242

1.72

2.86

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

235

1.73

2.86

1.0

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.21

2.85

1.0

1.2

2273.87

4012.79

ng/l

0.49

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

501

1.49

2.83

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

462

1.51

2.83

1.5

1.2

17.21

16.71

umol/l

0.47

409

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.49

2.83

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

167

1239

1.30

2.81

1.1

4.52

6.53

nmol/l

0.35

250

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

5.20

2.78

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

458

1.50

2.73

1.3

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

203

1551

1.27

2.73

1.1

1.0

303.46

289.11

mg/l

1.99

179

1384

(3026470) Cobalt [Mass/volume] in Blood

204

1560

1.26

2.73

2.0

3.56

3.82

ug/l

0.23

184

1435

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

313

1.61

2.71

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

199

1519

1.27

2.70

2.1

2.0

2.34

2.35

ug/l

0.01

153

1275

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

118

839

1.36

2.68

1.1

1537.40

1564.28

miu/ml

0.09

118

839

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

155

1.87

2.66

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

176

1.81

2.65

1.8

1.7

1.75

1.62

mg/l

0.23

145

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

111

784

1.37

2.63

1.4

1.3

3.71

4.02

umol/l

0.42

104

712

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.21

2.61

1.1

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

4.07

2.59

1.3

—

(4034850) Laboratory test

858

7440

1.12

2.58

14.6

10.3

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.62

2.57

1.1

1.0

—

(3018133) Calcium [Moles/volume] in Urine

273

1.63

2.55

1.8

1.6

2.75

2.67

mmol/l

0.09

241

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

465

3878

1.16

2.55

2.1

1.9

186.55

195.97

pmol/l

1.23

438

3631

(3034614) HLA Ag [Interpretation]

3.04

2.53

1.3

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

331

3780

0.84

2.46

1.6

1.7

—

(3017400) Magnesium [Moles/volume] in Urine

2.95

2.45

1.1

1.0

2.86

2.34

mmol/l

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

186

1431

1.26

2.41

1.7

2.0

17.56

16.80

nmol/l

0.66

176

1334

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

409

1.49

2.40

2.2

1.7

3.21

2.87

ug/l

0.14

240

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

887

0.69

2.37

1.4

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2968

30193

0.94

2.37

1.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.27

2.36

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

2.51

2.35

1.0

0.00

0.10

u/ml

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.34

2.35

1.4

1.0

1.51

0.50

umol/24h

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

2.34

2.35

1.0

0.05

0.21

u/ml

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

102

726

1.36

2.35

1.6

1.4

59.63

56.93

0.32

618

(3017509) Phencyclidine [Presence] in Urine

148

1.83

2.35

2.1

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

116

843

1.33

2.33

1.1

836.76

634.26

ng/l

0.12

199

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

381

3157

1.17

2.31

1.1

67.33

4378.07

iu/ml

0.66

637

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.80

2.30

1.4

1.3

11.80

37.78

e6/l

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.06

2.24

1.1

16.94

26.00

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.06

2.24

1.1

34.50

34.23

u/ml

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

144

1.81

2.21

1.0

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

202

1.67

2.20

2.3

2.2

72.32

58.64

1.42

127

(3033923) Metanephrine [Moles/time] in 24 hour Urine

490

1.42

2.18

1.2

1.1

0.65

0.80

umol/24h

0.47

230

(3035611) Eosinophils/100 leukocytes in Synovial fluid

159

1.76

2.18

2.4

1.6

1.00

0.79

0.18

122

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

203

1.67

2.17

1.1

8.92

20.14

iu/ml

1.20

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

634

5470

1.12

2.15

1.1

3.85

7.73

u/ml

2.31

594

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

160

1.75

2.14

1.0

1.3

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.02

2.13

1.4

1.6

0.75

0.13

u/l

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.02

2.13

1.1

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

381

1.47

2.12

6.3

6.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

485

1.41

2.12

1.2

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

105

1.93

2.10

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

119

1.87

2.08

1.3

1.2

0.06

0.07

g/l

0.33

(3027923) C peptide [Moles/volume] in Serum or Plasma

158

1217

1.26

2.08

1.4

1.5

1.35

1.21

nmol/l

0.68

119

944

(3036005) Urine sediment comments by Light microscopy Narrative

3.56

2.07

1.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

169

1.71

2.07

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

192

1512

1.23

2.07

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.20

2.07

1.9

1.1

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.20

2.07

5.7

6.3

1.40

1.20

mg/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

133

1629

0.79

2.04

1.4

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

369

1.47

2.03

1.8

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

311

2568

1.17

2.02

1.1

3.87

3.61

u/ml

0.08

103

1130

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.97

2.02

1.6

1.4

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

581

1.36

1.99

1.4

1.6

—

558.50

iu/ml

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

128

1.81

1.99

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

316

1.50

1.98

2.7

2.8

0.71

0.53

u/field

0.62

316

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.61

1.97

1.0

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

591

1.36

1.96

1.4

1.3

40.88

36.31

0.52

391

(3032743) Legionella sp IgG Ab [Presence] in Serum

143

1.76

1.96

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

127

961

1.28

1.96

1.2

153.06

159.83

mmol/24h

0.44

127

961

(3020491) Glucose [Moles/volume] in Blood

206

1646

1.21

1.95

2.3

1.9

7.45

7.02

mmol/l

1.01

153

1152

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.03

1.94

1.4

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

181

1.65

1.90

1.2

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

304

1.49

1.89

1.3

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

269

3043

0.85

1.87

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

481

1.39

1.87

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.91

1.86

8.5

11.9

928.43

297.23

e6/l

0.36

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

441

1.40

1.86

1.3

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

146

1.72

1.84

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

392

3321

1.14

1.83

1.3

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

618

5384

1.11

1.82

1.9

1.7

40.14

43.12

nmol/l

2.96

605

5199

(3041672) Baker's yeast Ab [Presence] in Serum

2.01

1.80

1.1

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

585

1.34

1.78

2.8

3.0

7.50

7.68

mg/l

0.08

473

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

662

5799

1.10

1.76

2.5

2.2

135.78

109.97

ug/min

0.60

404

3365

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

192

2221

0.83

1.76

1.6

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

149

1168

1.23

1.74

2.2

105.79

111.98

ug/min

0.04

266

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

120

1.77

1.73

1.1

3.20

3.22

u/l

—

(4146454) Self-monitoring of blood glucose

243

2742

0.85

1.68

2.5

2.7

—

(3001729) Color of Synovial fluid

189

1.58

1.65

2.2

1.5

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.58

1.64

2.8

4.9

—

(37021550) Renin [Units/volume] in Plasma --upright

461

1.36

1.63

1.3

1.2

114.01

59.90

mu/l

0.90

335

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8298

78376

1.03

1.62

5.1

3.45

3.63

ug/l

0.19

7355

69983

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.45

1.56

2.6

1.6

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.99

1.55

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.90

1.52

1.7

2.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

408

3516

1.12

1.52

1.7

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

206

1692

1.18

1.52

1.3

1.2

9.61

8.97

mmol/l

1.05

194

1612

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

312

1.42

1.51

1.2

1.4

54.85

51.96

0.14

142

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

501

1.33

1.51

2.3

2.4

6.62

7.57

mmol/l

2.42

318

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

171

1.58

1.50

1.1

1.2

31.33

21.98

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.86

1.49

1.1

1.0

5.18

5.44

mmol/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

732

1.27

1.47

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

127

1.67

1.46

1.0

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

2.76

1.44

1.2

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.35

1.44

1.0

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

158

1.59

1.43

1.2

1.5

33.53

38.70

0.23

102

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

234

2608

0.87

1.43

1.5

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

308

1.41

1.42

1.1

1.0

0.47

1.63

u/ml

0.70

250

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

549

1.30

1.41

2.4

192.78

151.21

au/ml

0.26

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

213

1.50

1.40

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

609

6412

0.92

1.39

1.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

206

1.50

1.38

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

145

1.60

1.36

1.7

5.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

142

1142

1.20

1.36

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.17

1.35

1.0

—

(3024316) Viscosity of Plasma

108

1.70

1.35

2.3

1.7

1.78

1.65

mpas

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

108

1.70

1.35

1.2

—

(36303858) Crystals [Presence] in Urine

2.41

1.30

1.0

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

147

1.58

1.30

1.5

1.1

—

(3001556) Androgen free Index in Serum or Plasma

102

1.70

1.29

2.5

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

660

1.26

1.29

2.5

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

219

2430

0.87

1.29

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1112

10106

1.07

1.28

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

259

1.42

1.26

11.2

8.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

219

2425

0.87

1.26

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

292

1.39

1.25

2.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.02

1.24

1.3

1.1

1.56

2.63

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.68

1.23

1.0

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

477

1.30

1.22

2.0

1.6

189.91

127.38

au/ml

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

221

2439

0.87

1.22

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

221

2437

0.87

1.21

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

212

1784

1.15

1.20

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

652

6793

0.93

1.20

1.8

1.7

4.65

3.81

mg/l

1.07

527

5006

(3005011) Chlamydia sp Ab [Titer] in Serum

270

1.40

1.20

1.6

1.7

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.75

1.18

1.0

1.1

2.83

0.14

u/ml

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

2.09

1.17

1.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.54

1.16

1.0

—

(3016330) Potassium [Moles/time] in 24 hour Urine

305

1.36

1.15

1.3

1.2

—

84.75

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.70

1.15

1.1

1.0

0.00

0.20

u/ml

0.82

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

330

1.35

1.15

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

181

2010

0.87

1.12

1.9

1.7

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.41

1.10

1.0

1.5

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.41

1.10

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

745

1.22

1.10

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1585

14628

1.05

1.09

1.3

1.2

—

(40762814) Titanium [Mass/volume] in Blood

443

1.29

1.09

2.3

3.09

3.52

ug/l

0.66

162

(3009015) Lactate [Moles/volume] in Synovial fluid

267

1.37

1.09

1.2

1.3

6.28

6.50

mmol/l

0.05

129

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

162

1.49

1.09

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

178

1.47

1.09

2.3

2.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

108

1.61

1.08

3.7

3.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

203

1.43

1.06

8.2

5.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

212

1.41

1.04

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.05

1.02

1.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

301

2624

1.11

1.01

1.2

1.1

—

(3005033) Fetal Nuchal fold Thickness US

180

1980

0.88

1.00

1.4

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.19

0.99

1.2

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

281

1.34

0.98

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

135

1120

1.16

0.98

4.1

3.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.61

0.98

11.6

8.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

315

1.32

0.97

1.0

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

0.58

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

187

2047

0.88

0.97

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

170

1437

1.14

0.96

1.7

1.4

2.67

4.00

ug/l

1.77

126

1166

(3015183) Erythrocyte sedimentation rate

109

890

1.18

0.96

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

21377

205224

1.02

0.95

6.6

6.0

40.75

40.13

mmol/mol

16.97

19739

188352

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.77

0.95

5.4

9.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

108

1226

0.85

0.93

1.3

1.51

1.55

g/l

0.90

108

1226

(3003740) Influenza virus B Ag [Presence] in Specimen

300

2629

1.10

0.93

1.2

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.23

0.93

1.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.88

0.93

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.61

0.92

1.0

265.71

198.64

pmol/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

182

1987

0.88

0.92

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

243

1.35

0.91

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

210

1.38

0.91

1.1

1.0

0.77

0.73

u/ml

0.02

155

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.70

0.90

5.4

5.6

511.83

423.22

umol/l

0.66

(1617658) Protocol used for examination of sentinel lymph nodes

196

1682

1.13

0.90

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6359

62508

0.98

0.90

4.3

4.4

21.57

22.08

1.92

3123

31246

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.59

0.89

1.3

1.2

1.64

1.78

mg/l

—

(3000963) Hemoglobin [Mass/volume] in Blood

25119

243412

0.97

0.87

38.4

21.7

131.02

134.73

g/l

259.51

24857

239346

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.00

0.86

1.7

1.1

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.00

0.86

1.2

1.0

0.01

0.13

u/ml

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

139

1.46

0.86

1.1

1.5

12.38

12.73

0.03

(3000285) Sodium [Moles/volume] in Blood

306

1.29

0.84

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

219

1901

1.11

0.84

4.1

5.0

119.84

114.10

u/ml

0.04

583

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

124

1.48

0.84

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

615

6314

0.94

0.83

1.4

1.3

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.76

0.83

1.0

—

(3026361) Erythrocytes [#/volume] in Blood

25117

243358

0.97

0.82

38.2

21.6

4.37

4.46

e12/l

138.70

24547

235418

(3022475) Manganese [Moles/volume] in Blood

125

1.47

0.81

1.5

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

855

7847

1.05

0.80

1.9

1.8

—

(3024731) MCV [Entitic volume]

25117

243344

0.97

0.80

38.0

21.5

91.58

91.27

19.83

24839

239281

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

122

1025

1.15

0.80

5.3

527.75

4050.09

u/ml

0.49

179

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.79

0.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

353

3153

1.08

0.77

1.1

1.23

1.76

u/ml

0.90

182

1520

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

22186

215225

0.98

0.76

5.1

4.7

6.06

5.99

mmol/l

12.05

20189

194868

(3010813) Leukocytes [#/volume] in Blood

25122

243367

0.97

0.76

38.2

21.6

7.02

6.76

e9/l

37.80

24562

235439

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

119

1.46

0.76

1.0

1.4

0.30

1.92

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

160

1.39

0.75

1.1

1.0

—

(3035941) MCH [Entitic mass]

25117

243311

0.97

0.75

38.0

21.5

30.25

30.36

17.27

24840

239253

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.69

0.75

1.2

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.57

0.75

1.1

—

(3006270) Folate [Moles/volume] in Blood

233

2047

1.10

0.74

1.2

312.23

349.53

nmol/l

1.57

184

1666

(3018001) Oat IgE Ab [Units/volume] in Serum

112

1.47

0.73

1.1

1.0

0.34

0.23

u/ml

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.61

0.72

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

229

1.31

0.71

1.3

1.1

1.86

1.70

umol/24h

0.45

229

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.93

0.71

1.6

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

221

1.31

0.70

1.2

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

546

1.19

0.67

1.1

1.2

348.25

288.51

pmol/l

0.52

391

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

133

1441

0.89

0.66

1.4

1.3

240.12

164.09

pmol/l

0.55

133

1441

(3003888) Timothy IgE Ab [Units/volume] in Serum

314

2817

1.08

0.65

1.0

1.1

3.89

4.24

u/ml

0.17

165

1341

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

254

2660

0.92

0.64

1.3

7.62

7.43

mmol/l

0.43

225

2286

(3007461) Platelets [#/volume] in Blood

25114

243201

0.98

0.64

38.2

21.6

249.40

248.12

e9/l

2.11

24615

236147

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

676

0.84

0.64

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.49

0.63

1.0

1.1

306.23

263.20

nmol/l

0.28

(3013762) Body weight Measured

1.58

0.61

1.4

1.1

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.28

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

161

1.32

0.56

2.5

2.2

8.70

17.19

—

(3018291) Platelet Ab [Presence] in Serum

1.66

0.56

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

103

1.41

0.55

1.0

1.1

8.20

8.37

mmol/l

0.14

103

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

213

1.27

0.55

1.3

1.2

0.26

nmol/l

0.01

142

(3032868) Hemoglobin electrophoresis panel in Blood

154

1.32

0.54

1.9

1.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.45

0.53

1.1

—

mmol/l

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.45

0.53

1.1

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

299

2708

1.07

0.52

1.0

1.1

0.91

0.98

u/ml

0.10

127

1062

(3010726) Horse dander IgE Ab [Units/volume] in Serum

278

2513

1.07

0.51

1.1

1.19

1.22

u/ml

0.03

141

1199

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

1068

0.89

0.50

1.3

5.73

5.91

mmol/l

1.05

1006

(3009542) Hematocrit [Volume Fraction] of Blood

25111

243059

0.98

0.50

38.5

21.7

39.40

40.05

2.94

23642

225991

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

148

1562

0.91

0.50

1.0

39.10

43.43

ng/l

0.72

1060

(3020650) Glucose [Presence] in Urine

528

1.15

0.49

1.5

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

148

1559

0.92

0.48

1.0

764.11

714.90

ng/l

0.74

1042

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

148

1553

0.92

0.45

1.0

302.10

349.45

ng/l

0.84

100

1073

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

142

1.29

0.44

1.0

1.2

16.80

14.33

nmol/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

191

0.76

0.44

1.1

1.0

—

(3022689) Creatine [Moles/volume] in Urine

671

0.88

0.44

1.9

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

212

1.23

0.44

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1541

15233

0.98

0.43

1.4

1.3

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.41

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.41

0.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

960

0.90

0.40

1.1

1.0

0.99

0.82

u/ml

0.24

217

(3020874) Milk IgE Ab [Units/volume] in Serum

980

0.91

0.40

1.1

1.0

2.70

1.09

u/ml

0.30

311

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.40

0.0

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

448

1.14

0.40

1.1

1.0

0.66

1.39

u/ml

0.71

228

(40768800) Prostate Pathology biopsy report

524

4868

1.04

0.39

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

207

1.21

0.38

1.2

—

(3025130) Human papilloma virus identified in Specimen

259

2367

1.06

0.38

1.6

1.7

—

(3045462) Protein/Creatinine [Ratio] in Urine

120

1.29

0.38

3.4

3.1

87.08

47.22

g/mol

0.36

105

(3022725) Serotonin [Moles/volume] in Serum

1.26

0.35

1.7

1.4

718.56

907.84

nmol/l

—

(3009677) Dengue virus Ab [Presence] in Serum

1.26

0.35

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2932

28717

0.98

0.35

4.5

4.7

31.71

32.73

5.72

2120

19369

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

162

0.77

0.35

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

267

0.83

0.34

1.1

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

364

1.14

0.33

3.2

3.0

105.28

121.97

ng/l

0.13

123

(3000034) Microalbumin [Mass/volume] in Urine

215

2190

0.95

0.32

3.2

3.0

74.11

46.70

mg/l

0.86

157

1579

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

123

1.26

0.32

1.0

0.01

0.02

u/ml

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

203

1.19

0.32

2.8

2.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

108

967

1.08

0.31

1.1

10.16

6.07

u/ml

0.69

145

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6032

58724

0.99

0.30

1.7

1.6

1.47

1.35

mmol/l

17.55

5016

48909

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.28

0.30

1.0

1.4

1.20

0.32

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1020

0.93

0.29

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

497

1.11

0.29

1.5

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

657

6172

1.03

0.29

1.8

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

125

1.24

0.29

1.0

0.00

0.14

u/ml

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

146

1328

1.06

0.28

5.6

6.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

230

0.84

0.28

1.4

1.7

—

(4212803) Bone marrow aspirate examination

233

1.16

0.28

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

464

1.10

0.26

1.1

1.0

12.05

10.23

u/ml

0.18

247

(4094501) Cardiovascular stress test using bicycle ergometer

655

6175

1.02

0.24

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

840

0.93

0.24

1.0

0.45

0.71

u/ml

0.28

210

(3012989) Citrate [Moles/time] in 24 hour Urine

1.30

0.23

1.2

1.5

1.44

2.20

mmol/24h

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.27

0.22

2.2

1.2

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

106

969

1.06

0.20

1.3

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

104

1.21

0.20

1.8

1.5

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

122

1.19

0.20

1.1

1.0

0.12

0.47

u/ml

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

363

0.90

0.20

1.1

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.18

0.19

1.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

123

1.18

0.19

1.7

1.4

359.00

340.24

umol/24h

0.11

123

(3008607) Semen analysis panel

1.21

0.18

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4597

44671

0.99

0.18

3.1

0.81

0.79

ug/l

0.38

3229

30335

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.17

0.17

1.9

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

599

1.06

0.17

1.7

1.6

10.31

9.07

ug/l

0.89

599

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

608

0.94

0.17

1.5

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

134

1.15

0.16

1.2

1.4

—

21331.78

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

116

1.17

0.16

1.2

1.4

1.00

1.11

u/field

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

109

1096

0.96

0.14

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2370

22722

1.01

0.13

1.6

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

268

1.08

0.12

1.0

81.85

81.80

ug/l

0.00

205

(3003577) Lead [Moles/volume] in Blood

147

1.12

0.12

1.3

0.30

0.18

umol/l

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

697

0.96

0.11

1.7

1.9

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

480

0.95

0.11

1.1

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

151

0.90

0.10

1.2

—

(3007733) Chloride [Moles/volume] in Urine

1.12

0.10

1.0

1.1

86.80

80.31

mmol/l

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

1.10

0.09

1.0

1.1

—

23.24

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

220

2166

0.98

0.09

1.1

3.50

3.27

u/ml

0.08

103

977

(3013945) Hepatitis B virus e Ab [Presence] in Serum

103

1.13

0.09

1.8

1.5

—

(40758358) Immune stain study

103

1.13

0.09

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

282

1.06

0.08

1.2

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

235

1.07

0.08

2.3

2.4

8.30

7.28

mmol/l

0.82

108

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.04

0.08

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.06

0.07

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

227

1.06

0.07

2.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.02

0.07

1.3

1.2

1.43

1.32

—

(3051101) Glucose [Moles/volume] in Cord blood

460

0.97

0.06

5.0

5.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

225

0.94

0.05

2.9

3.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

175

0.94

0.05

1.6

2.8

4644.42

53.03

pmol/l

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

224

0.95

0.05

5.8

6.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

116

1.08

0.04

1.3

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

116

1.08

0.04

1.0

0.01

0.65

u/ml

—

(3003338) MCHC [Mass/volume]

18950

182902

1.00

0.04

33.3

19.1

329.92

332.08

g/l

187.18

18791

181291

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3077

29746

1.00

0.02

10.5

7.4

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

152

0.95

0.02

1.0

0.02

0.14

u/ml

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

211

2032

1.00

0.00

1.0

1.1

3.78

3.34

u/ml

0.11

783

(40765089) Chromosome analysis panel - Blood by G-banded

323

0.99

0.00

1.1

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

183

1770

1.00

0.00

1.0

0.17

0.44

u/ml

1.07

483

(3041806) Other cells [#/volume] in Blood by Manual count

314

0.98

0.00

1.8

1.6

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

1.99

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.7

—

3.57

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.97

-0.00

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.94

-0.00

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.96

-0.00

1.1

1.0

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

2.4

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_VTE and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_VTE	2.165 [1.99, 2.36]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.076

During the follow-up period (1.1.1998 — 31.12.2019), 32766 out of 80974 females with I9_VTE died.

Males

Parameter	HR [95% CI]	p-value
I9_VTE	2.234 [2.03, 2.46]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 24507 out of 61597 males with I9_VTE died.

Mortality risk

Mortality risk for people of age

years, who have I9_VTE.

N-year risk	Females	Males
1	0.205%	0.471%
5	1.27%	2.114%
10	2.873%	5.435%
15	5.339%	10.021%
20	9.226%	17.1%

Relationships between endpoints

↥

Index endpoint: I9_VTE – Venous thromboembolism

GWS hits: 61

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Venous thromboembolism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints